Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
NEU.INH_VIP.develop_niche: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 122 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bipolar disorder | PSYCH000023 | 84.96 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 2 | Water consumption | DTSUP000004 | 67.72 | Diet and Supplement | Neural / glial | 104 | 3 | 4 | 14 | |
| 3 | Reproductive timing | BEHAV000011 | 67.26 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 4 | Educational attainment, none | SOCIO000001 | 58.22 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 5 | Social activity, none | SOCIO000018 | 57.64 | Socioeconomic | Neural / glial | 3 | 4 | 14 | 27 | |
| 6 | Worry | PSYCH000032 | 56.03 | Psychiatric | Neural / glial | 94 | 2 | 3 | 5 | |
| 7 | Neuroticism | PSYCH000034 | 49.99 | Psychiatric | Neural / glial | 77 | 3 | 6 | 12 | |
| 8 | Social support | SOCIO000022 | 48.98 | Socioeconomic | Neural / glial | 21 | 5 | 9 | 15 | |
| 9 | Food preparation preference | DTSUP000021 | 46.83 | Diet and Supplement | Neural / glial | 51 | 4 | 9 | 6 | |
| 10 | Vaccination | IMMUN000085 | 46.31 | Immunologic | Neural / glial | 10 | 5 | 10 | 12 | |
| 11 | Psychiatric care | PSYCH000015 | 45.25 | Psychiatric | Neural / glial | 9 | 3 | 11 | 16 | |
| 12 | Daytime napping | BEHAV000015 | 44.80 | Behavioural | Neural / glial | 81 | 5 | 11 | 25 | |
| 13 | Residential stability | SOCIO000014 | 44.57 | Socioeconomic | Neural / glial | 3 | 4 | 7 | 9 | |
| 14 | Depression or anxiety | PSYCH000025 | 41.84 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 15 | Frailty, limited social support | SOCIO000017 | 41.72 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 16 | Dietary preference | DTSUP000008 | 41.44 | Diet and Supplement | Neural / glial | 53 | 3 | 7 | 12 | |
| 17 | Dyspnoea | RESPI000028 | 40.19 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 18 | Respiratory symptom | RESPI000032 | 38.39 | Respiratory | Neural / glial | 10 | 4 | 12 | 19 | |
| 19 | Professional qualification | SOCIO000003 | 38.38 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 20 | Processing speed | PSYCH000008 | 36.54 | Psychiatric | Neural / glial | 65 | 4 | 10 | 18 | |
| 21 | Drink temperature | DTSUP000003 | 36.11 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 22 | Falling risk | MISCL000040 | 36.08 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 23 | Coffee preference | DTSUP000002 | 35.68 | Diet and Supplement | Neural / glial | 139 | 4 | 10 | 14 | |
| 24 | Fat mass | BCOMP000005 | 35.38 | Body composition | Neural / glial | 607 | 3 | 8 | 21 | |
| 25 | Arm fat percentage | BCOMP000012 | 35.36 | Body composition | Neural / glial | 328 | 4 | 7 | 13 | |
| 26 | Disability allowance, none | SOCIO000016 | 34.74 | Socioeconomic | Neural / glial | 0 | 4 | 18 | 26 | |
| 27 | Premature cardiac beat | CARDI000023 | 34.53 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 28 | Educational attainment | SOCIO000002 | 34.47 | Socioeconomic | Neural / glial | 143 | 5 | 11 | 23 | |
| 29 | Severe mental illness | PSYCH000017 | 34.39 | Psychiatric | Neural / glial | 0 | 4 | 8 | 10 | |
| 30 | Body mass index, BMI | BMORP000002 | 33.62 | Body morphology | Neural / glial | 1,808 | 5 | 9 | 17 | |
| 31 | Vegetable preference | DTSUP000020 | 33.30 | Diet and Supplement | Neural / glial | 91 | 3 | 8 | 18 | |
| 32 | Creativity | PSYCH000003 | 31.77 | Psychiatric | Neural / glial | 10 | 4 | 13 | 23 | |
| 33 | Medication, hypnotic or sedative | PSYCH000020 | 31.55 | Psychiatric | Neural / glial | 1 | 5 | 14 | 26 | |
| 34 | Mood disorder | PSYCH000028 | 31.50 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 35 | Cognitive function | PSYCH000002 | 31.04 | Psychiatric | Neural / glial | 282 | 3 | 5 | 17 | |
| 36 | Social activity | SOCIO000020 | 30.38 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 37 | Household income | SOCIO000026 | 29.98 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 38 | Mood symptoms | PSYCH000029 | 29.79 | Psychiatric | Neural / glial | 41 | 3 | 7 | 10 | |
| 39 | Seafood preference | DTSUP000016 | 29.73 | Diet and Supplement | Neural / glial | 76 | 3 | 5 | 10 | |
| 40 | Meat preference | DTSUP000015 | 29.65 | Diet and Supplement | Neural / glial | 47 | 5 | 12 | 14 | |
| 41 | Frailty, disability | MISCL000038 | 28.56 | Miscellaneous | Neural / glial | 3 | 3 | 10 | 4 | |
| 42 | Medication use | MISCL000037 | 28.28 | Miscellaneous | Neural / glial | 67 | 6 | 15 | 20 | |
| 43 | Negative affect | PSYCH000030 | 27.96 | Psychiatric | Neural / glial | 83 | 3 | 8 | 9 | |
| 44 | Occupational physical activity | BEHAV000006 | 27.96 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 45 | Abdominal and pelvic pain | GASTR000043 | 27.55 | Gastrointestinal | Neural / glial | 0 | 4 | 7 | 13 | |
| 46 | Non-cancer illness burden | MISCL000029 | 27.40 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 47 | Intelligence | PSYCH000004 | 27.38 | Psychiatric | Neural / glial | 305 | 2 | 3 | 13 | |
| 48 | Sleep behaviour | BEHAV000016 | 26.41 | Behavioural | Neural / glial | 57 | 4 | 8 | 7 | |
| 49 | Fruit preference | DTSUP000012 | 25.96 | Diet and Supplement | Neural / glial | 59 | 4 | 8 | 19 | |
| 50 | Commuting transport | SOCIO000004 | 25.82 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 51 | Self-rated health | MISCL000013 | 25.47 | Miscellaneous | Neural / glial | 29 | 5 | 10 | 17 | |
| 52 | CEBPB/PXN ratio | PRORT000592 | 25.37 | Protein ratios | Neural / glial | 0 | 3 | 6 | 17 | |
| 53 | Intestinal disorder | GASTR000012 | 25.09 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 54 | Waist circumference | BMORP000013 | 24.97 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 55 | Leg fat percentage | BCOMP000015 | 24.96 | Body composition | Neural / glial | 295 | 4 | 7 | 17 | |
| 56 | Loneliness | PSYCH000055 | 24.86 | Psychiatric | Neural / glial | 1 | 2 | 10 | 17 | |
| 57 | Reaction time | PSYCH000010 | 24.07 | Psychiatric | Neural / glial | 67 | 3 | 6 | 11 | |
| 58 | Chronic illness or disability | MISCL000004 | 23.48 | Miscellaneous | Neural / glial | 10 | 5 | 14 | 24 | |
| 59 | Cereal preference | DTSUP000010 | 22.18 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 60 | Metabolic syndrome | METBL000015 | 22.15 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 61 | Depression | PSYCH000024 | 21.86 | Psychiatric | Neural / glial | 57 | 3 | 8 | 12 | |
| 62 | Cannabis use | PSYCH000045 | 21.77 | Psychiatric | Neural / glial | 9 | 5 | 11 | 26 | |
| 63 | Citrulline | METAB000020 | 21.70 | Metabolites | Muscle / cardiac | 0 | 1 | 6 | 5 | |
| 64 | Beverage preference | DTSUP000001 | 21.68 | Diet and Supplement | Neural / glial | 155 | 3 | 9 | 15 | |
| 65 | Schizophrenia | PSYCH000036 | 21.41 | Psychiatric | Neural / glial | 9 | 5 | 12 | 23 | |
| 66 | Prospective memory | PSYCH000009 | 21.16 | Psychiatric | Neural / glial | 18 | 4 | 13 | 19 | |
| 67 | Electronic device use | BEHAV000017 | 20.97 | Behavioural | Neural / glial | 29 | 3 | 8 | 21 | |
| 68 | Medication use, pain etc, none | MISCL000032 | 20.76 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 69 | Alcohol consumption | PSYCH000041 | 20.66 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 70 | Consultant specialty, gastroenterology | GASTR000007 | 20.65 | Gastrointestinal | Neural / glial | 0 | 5 | 12 | 16 | |
| 71 | Alpha-1-antitrypsin deficiency | RESPI000005 | 20.63 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 72 | Viral hepatitis | IMMUN000076 | 20.32 | Immunologic | Neural / glial | 3 | 4 | 10 | 17 | |
| 73 | Alcohol use | PSYCH000043 | 20.32 | Psychiatric | Neural / glial | 16 | 4 | 8 | 13 | |
| 74 | Obesity | METBL000008 | 20.13 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 75 | Sun exposure | BEHAV000001 | 19.97 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 76 | HRG levels | PROLV000988 | 19.85 | Protein levels | Neural / glial | 68 | 4 | 12 | 26 | |
| 77 | Pregnancy complication, abortive | REPRO000027 | 19.49 | Reproductive | Neural / glial | 0 | 5 | 7 | 18 | |
| 78 | Taste preference | DTSUP000023 | 19.47 | Diet and Supplement | Neural / glial | 83 | 3 | 6 | 17 | |
| 79 | Disability allowance | SOCIO000019 | 19.46 | Socioeconomic | Neural / glial | 0 | 4 | 15 | 28 | |
| 80 | Flavour preference | DTSUP000022 | 19.41 | Diet and Supplement | Neural / glial | 94 | 3 | 8 | 18 | |
| 81 | Circadian timing | BEHAV000014 | 19.35 | Behavioural | Neural / glial | 79 | 2 | 9 | 16 | |
| 82 | Narcolepsy | NEURO000036 | 19.31 | Neurologic | Neural / glial | 17 | 4 | 13 | 30 | |
| 83 | Body size, childhood | BMORP000004 | 19.08 | Body morphology | Neural / glial | 188 | 2 | 5 | 5 | |
| 84 | Snack and fast-food preference | DTSUP000017 | 19.00 | Diet and Supplement | Neural / glial | 36 | 4 | 7 | 24 | |
| 85 | Female genital inflammation | REPRO000008 | 18.95 | Reproductive | Neural / glial | 0 | 2 | 4 | 4 | |
| 86 | Mood disorder, none | PSYCH000021 | 18.91 | Psychiatric | Neural / glial | — | 2 | 8 | 13 | |
| 87 | AXIN1/MAVS ratio | PRORT000175 | 18.63 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 88 | Medication, chronic lung disease | RESPI000006 | 18.55 | Respiratory | Neural / glial | 4 | 3 | 21 | 50 | |
| 89 | Medical condition | MISCL000028 | 18.54 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 90 | Transport mode | BEHAV000009 | 18.50 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 91 | Smoking behaviour | PSYCH000046 | 18.23 | Psychiatric | Neural / glial | 201 | 5 | 10 | 23 | |
| 92 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 18.12 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 93 | Sexual behaviour | BEHAV000012 | 18.05 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 94 | Dietary change, none | DTSUP000005 | 18.02 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 95 | Gastritis and duodenitis | GASTR000049 | 17.72 | Gastrointestinal | Neural / glial | — | 2 | 7 | 5 | |
| 96 | Frailty, poorer cognition | PSYCH000001 | 17.69 | Psychiatric | Neural / glial | 40 | 2 | 7 | 9 | |
| 97 | Chest pain | CARDI000052 | 17.58 | Cardiac | Neural / glial | 19 | 4 | 16 | 46 | |
| 98 | RELL1 levels | PROLV001721 | 17.53 | Protein levels | Neural / glial | 3 | 2 | 4 | 14 | |
| 99 | Frailty, general | MISCL000039 | 17.38 | Miscellaneous | Neural / glial | 20 | 4 | 7 | 19 | |
| 100 | Sedentary behaviour | BEHAV000008 | 16.81 | Behavioural | Neural / glial | 111 | 4 | 9 | 20 | |
| 101 | Physical activity | BEHAV000007 | 16.76 | Behavioural | Neural / glial | 105 | 3 | 7 | 24 | |
| 102 | Anxiety | PSYCH000022 | 16.74 | Psychiatric | Neural / glial | 45 | 4 | 8 | 19 | |
| 103 | CNPY4/STAT5B ratio | PRORT000681 | 16.72 | Protein ratios | Hepatocyte | 2 | 3 | 12 | 17 | |
| 104 | Irritable bowel syndrome | GASTR000004 | 16.63 | Gastrointestinal | Neural / glial | 3 | 2 | 7 | 23 | |
| 105 | Body fat percentage | BCOMP000004 | 16.63 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 106 | Age at onset of walking | NEURO000023 | 16.52 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 107 | Sleep duration | PSYCH000040 | 16.48 | Psychiatric | Neural / glial | 9 | 6 | 14 | 17 | |
| 108 | Trunk fat percentage | BCOMP000018 | 16.43 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 109 | Depressive symptoms | PSYCH000026 | 16.41 | Psychiatric | Neural / glial | 28 | 2 | 7 | 14 | |
| 110 | Adjustment disorder | PSYCH000051 | 16.10 | Psychiatric | Neural / glial | 0 | 5 | 6 | 16 | |
| 111 | Digestive system symptoms | GASTR000044 | 15.82 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 112 | NPDC1/TAFA5 ratio | PRORT001595 | 15.69 | Protein ratios | Vascular | 24 | 4 | 9 | 29 | |
| 113 | PPIE levels | PROLV001607 | 15.57 | Protein levels | Neural / glial | 0 | 1 | 7 | 9 | |
| 114 | CNTNAP2/DPP6 ratio | PRORT000690 | 15.54 | Protein ratios | Neural / glial | 0 | 2 | 13 | 27 | |
| 115 | Grain and bakery preference | DTSUP000013 | 15.48 | Diet and Supplement | Neural / glial | 49 | 4 | 9 | 22 | |
| 116 | Multiple system atrophy | NEURO000020 | 15.42 | Neurologic | Neural / glial | 0 | 3 | 6 | 16 | |
| 117 | Alcohol preference | PSYCH000042 | 14.92 | Psychiatric | Neural / glial | 14 | 4 | 10 | 11 | |
| 118 | Dietary pattern | DTSUP000007 | 14.74 | Diet and Supplement | Neural / glial | 279 | 3 | 7 | 16 | |
| 119 | Soft tissue disorder | MSKEL000069 | 14.69 | Musculoskeletal | Neural / glial | 21 | 2 | 7 | 6 | |
| 120 | Wellbeing | PSYCH000056 | 14.65 | Psychiatric | Neural / glial | 2 | 2 | 8 | 17 | |
| 121 | Family history, chronic disease | MISCL000009 | 14.41 | Miscellaneous | Vascular | 0 | 5 | 13 | 8 | |
| 122 | Housing type | SOCIO000013 | 14.31 | Socioeconomic | Neural / glial | — | 7 | 14 | 22 | |
| 123 | Insomnia | PSYCH000038 | 14.31 | Psychiatric | Neural / glial | 63 | 2 | 6 | 14 | |
| 124 | CEP85/ZBTB16 ratio | PRORT000604 | 13.73 | Protein ratios | Muscle / cardiac | 20 | 3 | 12 | 18 | |
| 125 | Alcoholic liver disease | HPBIL000033 | 13.70 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 126 | MGAT2 levels | PROLV001308 | 13.62 | Protein levels | Neural / glial | 2 | 4 | 11 | 21 | |
| 127 | CFHR1 levels | PROLV000414 | 13.14 | Protein levels | Neural / glial | 6 | 2 | 6 | 10 | |
| 128 | Corrective lens use | OPHTH000032 | 12.99 | Ophthalmic | Neural / glial | 66 | 8 | 14 | 25 | |
| 129 | LEPR/NTRK2 ratio | PRORT001448 | 12.95 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 130 | Hearing aid use | AUDIO000011 | 12.59 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 131 | Medication, GERD | GASTR000014 | 12.37 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 132 | Major depressive disorder | PSYCH000027 | 12.36 | Psychiatric | Neural / glial | 0 | 2 | 6 | 6 | |
| 133 | FGR levels | PROLV000804 | 12.30 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 134 | Sphingolipids | LIPID000071 | 12.13 | Lipids | Neural / glial | 0 | 1 | 4 | 7 | |
| 135 | Bowel function | GASTR000002 | 12.06 | Gastrointestinal | Neural / glial | 18 | 5 | 9 | 11 | |
| 136 | CHGB levels | PROLV000427 | 12.01 | Protein levels | Neural / glial | 3 | 2 | 6 | 15 | |
| 137 | Pain, joint | MSKEL000036 | 11.84 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 138 | PER3 levels | PROLV001537 | 11.75 | Protein levels | Muscle / cardiac | 5 | 3 | 10 | 17 | |
| 139 | ITIH4 levels | PROLV001119 | 11.74 | Protein levels | Hepatocyte | 94 | 2 | 8 | 17 | |
| 140 | Study participation | BEHAV000004 | 11.73 | Behavioural | Neural / glial | 41 | 3 | 10 | 26 | |
| 141 | Hearing difficulty | AUDIO000012 | 11.72 | Auditory | Neural / glial | 134 | 1 | 7 | 6 | |
| 142 | COL6A3/CST3 ratio | PRORT000696 | 11.65 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 143 | BLVRB/HMBS ratio | PRORT000243 | 11.48 | Protein ratios | Neural / glial | 14 | 5 | 14 | 29 | |
| 144 | Urinary tract infection | IMMUN000074 | 11.32 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 145 | Household composition | SOCIO000010 | 11.29 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 146 | Mental distress | PSYCH000014 | 11.09 | Psychiatric | Muscle / cardiac | 2 | 7 | 11 | 20 | |
| 147 | Memory function | PSYCH000007 | 11.08 | Psychiatric | Neural / glial | 45 | 1 | 6 | 10 | |
| 148 | Social relationships | SOCIO000021 | 11.01 | Socioeconomic | Neural / glial | 17 | 5 | 9 | 17 | |
| 149 | Oesophageal disorder | GASTR000050 | 10.94 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 150 | Beta-cell function | METBL000036 | 10.90 | Metabolic | Neural / glial | 0 | 1 | 5 | 13 | |
| 151 | CCL25/PRSS27 ratio | PRORT000353 | 10.90 | Protein ratios | Lymphocyte | 1 | 2 | 9 | 18 | |
| 152 | ZNRF4 levels | PROLV002214 | 10.81 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 153 | Operation, urological | NEPHR000016 | 10.77 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 154 | Smoking dependency | PSYCH000047 | 10.72 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 155 | CST3/TAFA5 ratio | PRORT000787 | 10.64 | Protein ratios | Myeloid | 1 | 3 | 10 | 9 | |
| 156 | Medication, anti-depressant | PSYCH000019 | 10.56 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 157 | Bronchitis | RESPI000001 | 10.28 | Respiratory | Lymphocyte | 7 | 1 | 11 | 21 | |
| 158 | SEZ6 levels | PROLV001840 | 10.14 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 159 | Urinary system disorder | NEPHR000005 | 10.14 | Nephrourologic | Neural / glial | 1 | 2 | 7 | 9 | |
| 160 | Weight | BMORP000015 | 10.07 | Body morphology | Neural / glial | 1,549 | 3 | 8 | 22 | |
| 161 | DCXR/SCLY ratio | PRORT000878 | 10.04 | Protein ratios | Hepatocyte | 5 | 2 | 8 | 12 | |
| 162 | Pregnancy complication, preterm labour | REPRO000034 | 9.98 | Reproductive | Lymphocyte | 0 | 2 | 17 | 25 | |
| 163 | CIAPIN1/SNX9 ratio | PRORT000617 | 9.89 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 164 | Paroxysmal neurological disorder | NEURO000035 | 9.87 | Neurologic | Neural / glial | 21 | 3 | 4 | 10 | |
| 165 | Spread preference | DTSUP000018 | 9.79 | Diet and Supplement | Neural / glial | 14 | 2 | 6 | 13 | |
| 166 | Sleep apnoea | RESPI000035 | 9.62 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 167 | Pain, neck | MSKEL000040 | 9.59 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 168 | Gut microbial abundance, Rubneribacter | GASTR000035 | 9.58 | Gastrointestinal | Neural / glial | 0 | 2 | 10 | 19 | |
| 169 | UBAC1 levels | PROLV002132 | 9.58 | Protein levels | Muscle / cardiac | 4 | 2 | 6 | 11 | |
| 170 | Loose teeth | DENTA000012 | 9.53 | Dental | Neural / glial | 1 | 2 | 7 | 12 | |
| 171 | Passive smoking | MISCL000007 | 9.53 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 172 | Consultant specialty, cardiology | CARDI000037 | 9.51 | Cardiac | Vascular | 51 | 4 | 13 | 19 | |
| 173 | PIK3IP1/RGMB ratio | PRORT001665 | 9.38 | Protein ratios | Neural / glial | 0 | 0 | 8 | 11 | |
| 174 | Consultant specialty, anaesthetics | MISCL000015 | 9.33 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 175 | SNX9/STIP1 ratio | PRORT001801 | 9.32 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 176 | Housing tenure | SOCIO000012 | 9.26 | Socioeconomic | Neural / glial | 0 | 5 | 9 | 20 | |
| 177 | CALCOCO1/IKBKG ratio | PRORT000295 | 9.22 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 178 | PYY levels | PROLV001690 | 9.17 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 179 | Movement disorder | NEURO000015 | 9.10 | Neurologic | Neural / glial | 43 | 2 | 7 | 11 | |
| 180 | Sweets preference | DTSUP000019 | 9.06 | Diet and Supplement | Neural / glial | 88 | 4 | 7 | 13 | |
| 181 | Supplement use, mineral or vitamin | DTSUP000026 | 9.05 | Diet and Supplement | Neural / glial | 7 | 5 | 9 | 22 | |
| 182 | Gastrointestinal endoscopy | GASTR000042 | 8.96 | Gastrointestinal | Neural / glial | 13 | 2 | 8 | 11 | |
| 183 | Handedness | BEHAV000003 | 8.91 | Behavioural | Neural / glial | 0 | 5 | 14 | 31 | |
| 184 | Cortical thickness | NIMAG000010 | 8.89 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 185 | ELOA levels | PROLV000701 | 8.87 | Protein levels | Neural / glial | 5 | 6 | 12 | 31 | |
| 186 | Pain, generic | MSKEL000035 | 8.81 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 187 | Ocular alignment procedures | OPHTH000026 | 8.68 | Ophthalmic | Neural / glial | 1 | 2 | 5 | 18 | |
| 188 | Liver fat | HPBIL000023 | 8.65 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 189 | ATG4A/TPMT ratio | PRORT000150 | 8.47 | Protein ratios | Neural / glial | 0 | 3 | 7 | 13 | |
| 190 | MAP2K6/NT5C3A ratio | PRORT001486 | 8.31 | Protein ratios | Muscle / cardiac | 12 | 6 | 8 | 16 | |
| 191 | Functional gastrointestinal disorder | GASTR000003 | 8.27 | Gastrointestinal | Neural / glial | 0 | 1 | 6 | 18 | |
| 192 | Ocular refraction | OPHTH000033 | 8.12 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 193 | Circulatory disorder | VASCU000025 | 8.05 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 194 | Dairy preference | DTSUP000011 | 8.04 | Diet and Supplement | Neural / glial | 85 | 4 | 5 | 20 | |
| 195 | Risk-taking behaviour | BEHAV000013 | 8.01 | Behavioural | Neural / glial | 77 | 5 | 7 | 24 | |
| 196 | CIAPIN1/PLA2G4A ratio | PRORT000615 | 8.01 | Protein ratios | Myeloid | 0 | 2 | 6 | 14 | |
| 197 | Pain, multi-site | MSKEL000038 | 7.96 | Musculoskeletal | Neural / glial | 13 | 5 | 10 | 28 | |
| 198 | Mental disorder | PSYCH000013 | 7.94 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 199 | NBN levels | PROLV001376 | 7.91 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 200 | Dietary restriction | DTSUP000009 | 7.91 | Diet and Supplement | Neural / glial | 67 | 4 | 10 | 35 | |
| 201 | Autoimmune hepatitis | IMMUN000024 | 7.87 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 202 | PGLS levels | PROLV001545 | 7.78 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 203 | Suicidal behaviour | PSYCH000037 | 7.75 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 204 | PATE4 levels | PROLV001498 | 7.74 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 205 | Nephritis | NEPHR000024 | 7.64 | Nephrourologic | Hepatocyte | 24 | 0 | 5 | 9 | |
| 206 | Supplement use, dietary | DTSUP000024 | 7.62 | Diet and Supplement | Neural / glial | 7 | 5 | 10 | 20 | |
| 207 | Medication, proton pump inhibitor | GASTR000017 | 7.58 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 208 | ERBB2/GUSB ratio | PRORT001043 | 7.56 | Protein ratios | Hepatocyte | 25 | 3 | 13 | 29 | |
| 209 | Supplement use, glucosamine | DTSUP000025 | 7.56 | Diet and Supplement | Neural / glial | 0 | 2 | 7 | 19 | |
| 210 | COX5B/METAP1D ratio | PRORT000717 | 7.51 | Protein ratios | Hepatocyte | 10 | 3 | 9 | 12 | |
| 211 | Fatty acids, docosahexaenoic acid | LIPID000020 | 7.46 | Lipids | Hepatocyte | 789 | 4 | 9 | 16 | |
| 212 | CDC37/SNAP29 ratio | PRORT000541 | 7.46 | Protein ratios | Myeloid | 18 | 4 | 13 | 31 | |
| 213 | Medication, cardiovascular | VASCU000036 | 7.45 | Vascular | Neural / glial | 11 | 2 | 4 | 16 | |
| 214 | Stressful life events, none | PSYCH000050 | 7.45 | Psychiatric | Neural / glial | 7 | 6 | 15 | 10 | |
| 215 | Vehicle ownership | SOCIO000015 | 7.38 | Socioeconomic | Neural / glial | 2 | 4 | 8 | 18 | |
| 216 | AGT levels | PROLV000059 | 7.31 | Protein levels | Hepatocyte | 53 | 2 | 5 | 10 | |
| 217 | MAX/TDRKH ratio | PRORT001504 | 7.23 | Protein ratios | Myeloid | 0 | 4 | 11 | 11 | |
| 218 | Hashimoto thyroiditis | IMMUN000028 | 7.17 | Immunologic | Neural / glial | — | 2 | 4 | 8 | |
| 219 | Vitiligo | IMMUN000046 | 7.16 | Immunologic | Neural / glial | — | 0 | 3 | 6 | |
| 220 | Gait abnormality | NEURO000014 | 7.16 | Neurologic | Neural / glial | 0 | 4 | 11 | 17 | |
| 221 | Vitreous disorder | OPHTH000047 | 7.15 | Ophthalmic | Neural / glial | 1 | 2 | 6 | 7 | |
| 222 | HGF/MMP8 ratio | PRORT001282 | 7.08 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 19 | |
| 223 | Consultant specialty, general medicine | MISCL000016 | 7.07 | Miscellaneous | Neural / glial | 2 | 2 | 4 | 6 | |
| 224 | MINPP1 levels | PROLV001317 | 7.03 | Protein levels | Neural / glial | 0 | 5 | 15 | 23 | |
| 225 | Headache | NEURO000009 | 6.99 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 226 | Hospital admission | MISCL000022 | 6.95 | Miscellaneous | Neural / glial | 1 | 3 | 6 | 25 | |
| 227 | Occupational attainment | SOCIO000007 | 6.92 | Socioeconomic | Myeloid | 6 | 5 | 7 | 20 | |
| 228 | Joint injection | MSKEL000048 | 6.87 | Musculoskeletal | Neural / glial | 0 | 5 | 14 | 36 | |
| 229 | ARSA/GUSB ratio | PRORT000143 | 6.82 | Protein ratios | Hepatocyte | 21 | 4 | 9 | 26 | |
| 230 | NAGA levels | PROLV001371 | 6.79 | Protein levels | Myeloid | 46 | 5 | 9 | 12 | |
| 231 | RND3 levels | PROLV001743 | 6.77 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 232 | Hip circumference | BMORP000011 | 6.75 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 233 | SIRT2/STAT5B ratio | PRORT001787 | 6.70 | Protein ratios | Hepatocyte | 8 | 2 | 7 | 17 | |
| 234 | Birth weight availability | MISCL000005 | 6.70 | Miscellaneous | Neural / glial | 11 | 5 | 10 | 22 | |
| 235 | Cerebral ischaemia | VASCU000012 | 6.70 | Vascular | Neural / glial | 1 | 2 | 7 | 5 | |
| 236 | Potassium | METAB000049 | 6.69 | Metabolites | Muscle / cardiac | 178 | 0 | 4 | 5 | |
| 237 | Cutaneous abscess | IMMUN000057 | 6.63 | Immunologic | Neural / glial | 0 | 2 | 7 | 15 | |
| 238 | ATXN10/CASP10 ratio | PRORT000161 | 6.62 | Protein ratios | Granulosa cell | 1 | 4 | 9 | 24 | |
| 239 | HGF levels | PROLV000965 | 6.58 | Protein levels | Neural / glial | 29 | 4 | 13 | 15 | |
| 240 | Lysophosphatidylethanolamines | LIPID000055 | 6.55 | Lipids | Hepatocyte | 10 | 1 | 3 | 18 | |
| 241 | Household size | SOCIO000011 | 6.55 | Socioeconomic | Neural / glial | 0 | 4 | 9 | 17 | |
| 242 | Consultant specialty, urology | MISCL000020 | 6.54 | Miscellaneous | Neural / glial | 3 | 0 | 8 | 6 | |
| 243 | Cancer, Oropharynx | MALIG000022 | 6.54 | Malignancy | Neural / glial | 0 | 6 | 13 | 22 | |
| 244 | Sodium | METAB000050 | 6.46 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 245 | Trauma exposure | PSYCH000054 | 6.46 | Psychiatric | Neural / glial | 32 | 2 | 6 | 14 | |
| 246 | Anaemia | HEMAT000001 | 6.45 | Hematologic | Myeloid | 22 | 1 | 6 | 5 | |
| 247 | Pain, back | MSKEL000033 | 6.42 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 248 | Nephritic syndrome | NEPHR000009 | 6.38 | Nephrourologic | Lymphocyte | — | 2 | 9 | 21 | |
| 249 | Tryptophan | METAB000030 | 6.38 | Metabolites | Hepatocyte | 4 | 2 | 6 | 16 | |
| 250 | Inflammation and poor diet | MISCL000001 | 6.37 | Miscellaneous | Myeloid | 166 | 5 | 8 | 19 | |
| 251 | MOG/PTPRN2 ratio | PRORT001551 | 6.32 | Protein ratios | Neural / glial | 28 | 3 | 3 | 10 | |
| 252 | EGLN1/FOXO1 ratio | PRORT001002 | 6.32 | Protein ratios | Hepatocyte | 4 | 4 | 10 | 21 | |
| 253 | PXN levels | PROLV001688 | 6.32 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 254 | MSRA/PRDX5 ratio | PRORT001562 | 6.30 | Protein ratios | Neural / glial | 0 | 5 | 14 | 44 | |
| 255 | Employment status | SOCIO000005 | 6.30 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 256 | Wheeze | RESPI000034 | 6.29 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 257 | CALCOCO1/IRAG2 ratio | PRORT000297 | 6.29 | Protein ratios | Neural / glial | 0 | 2 | 18 | 34 | |
| 258 | Supplement use, mineral or vitamin, none | DTSUP000027 | 6.28 | Diet and Supplement | Neural / glial | 2 | 5 | 8 | 19 | |
| 259 | Cough | RESPI000027 | 6.17 | Respiratory | Myeloid | 0 | 4 | 7 | 11 | |
| 260 | DECR1/MAP2K6 ratio | PRORT000882 | 6.10 | Protein ratios | Muscle / cardiac | 19 | 3 | 10 | 16 | |
| 261 | Personality disorder | PSYCH000035 | 6.08 | Psychiatric | Hepatocyte | 0 | 1 | 5 | 15 | |
| 262 | CD84/SEMA4D ratio | PRORT000527 | 6.03 | Protein ratios | Myeloid | 13 | 2 | 5 | 11 | |
| 263 | Venous insufficiency | VASCU000065 | 6.01 | Vascular | Neural / glial | 1 | 1 | 4 | 12 | |
| 264 | KLK6/PTPRN2 ratio | PRORT001410 | 6.00 | Protein ratios | Neural / glial | 6 | 4 | 10 | 13 | |
| 265 | CFHR4 levels | PROLV000416 | 5.98 | Protein levels | Hepatocyte | 61 | 2 | 9 | 16 | |
| 266 | Auditory performance | AUDIO000009 | 5.97 | Auditory | Neural / glial | 0 | 4 | 11 | 26 | |
| 267 | Frailty, unhealthy lifestyle | BEHAV000002 | 5.96 | Behavioural | Myeloid | 5 | 5 | 9 | 16 | |
| 268 | Dietary change | DTSUP000006 | 5.94 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 0 | |
| 269 | Legume preference | DTSUP000014 | 5.93 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 18 | |
| 270 | Family medical history, none | MISCL000010 | 5.88 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 271 | Pregnancy complication, haemorrhage | REPRO000030 | 5.87 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 272 | CCL2 levels | PROLV000286 | 5.86 | Protein levels | Myeloid | 106 | 3 | 6 | 7 | |
| 273 | Weight change | BMORP000016 | 5.84 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 274 | RLN2 levels | PROLV001736 | 5.81 | Protein levels | Muscle / cardiac | 6 | 4 | 10 | 24 | |
| 275 | Stressful life events | PSYCH000053 | 5.80 | Psychiatric | Neural / glial | 0 | 5 | 9 | 21 | |
| 276 | Epilepsy | NEURO000034 | 5.79 | Neurologic | Myeloid | 0 | 2 | 5 | 19 | |
| 277 | TNFRSF11A levels | PROLV002060 | 5.77 | Protein levels | B / plasma cell | 31 | 1 | 4 | 8 | |
| 278 | Occupation | SOCIO000006 | 5.68 | Socioeconomic | Neural / glial | 1 | 1 | 4 | 6 | |
| 279 | PMVK/PRTFDC1 ratio | PRORT001693 | 5.66 | Protein ratios | Muscle / cardiac | 1 | 2 | 11 | 12 | |
| 280 | CACNA2D3 levels | PROLV000250 | 5.60 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 281 | Pyrimidine metabolites | METAB000063 | 5.54 | Metabolites | Granulosa cell | 0 | 1 | 7 | 16 | |
| 282 | SLC9A3R2 levels | PROLV001886 | 5.52 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 283 | Nerve root disorder | NEURO000030 | 5.52 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 284 | CNTN4 levels | PROLV000478 | 5.52 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 285 | Polyamine metabolites | METAB000059 | 5.46 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 286 | FSTL3 levels | PROLV000831 | 5.44 | Protein levels | Neural / glial | 17 | 2 | 3 | 8 | |
| 287 | Social trust | SOCIO000023 | 5.42 | Socioeconomic | Stromal / connective | 0 | 5 | 12 | 19 | |
| 288 | Heart rate response to exercise | CARDI000025 | 5.33 | Cardiac | Vascular | 12 | 0 | 6 | 5 | |
| 289 | Temporomandibular joint disorder | MSKEL000022 | 5.30 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 290 | Pain, limb | MSKEL000037 | 5.26 | Musculoskeletal | B / plasma cell | 1 | 5 | 10 | 20 | |
| 291 | Frailty, multimorbidity | METBL000012 | 5.26 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 292 | Musculoskeletal soft tissue disorder | MSKEL000029 | 5.23 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 293 | Heme malignancy, Myeloid | MALIG000045 | 5.14 | Malignancy | Hepatocyte | 0 | 1 | 6 | 15 | |
| 294 | Glomerular disease | NEPHR000006 | 5.14 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 295 | Chronic respiratory disease | RESPI000003 | 5.13 | Respiratory | Lymphocyte | 99 | — | — | — | |
| 296 | TPM2 levels | PROLV002095 | 5.10 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 297 | CRIP2 levels | PROLV000523 | 5.10 | Protein levels | Myeloid | 32 | 5 | 13 | 19 | |
| 298 | BTN2A1/IL18BP ratio | PRORT000257 | 5.09 | Protein ratios | Myeloid | 15 | 2 | 12 | 8 | |
| 299 | Benign neoplasm, Salivary gland | MALIG000006 | 5.07 | Malignancy | Neural / glial | 1 | 1 | 4 | 11 | |
| 300 | Ceramides | LIPID000065 | 5.06 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 301 | NCR3 levels | PROLV001383 | 5.05 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 302 | Medication, bone metabolism | MSKEL000025 | 5.02 | Musculoskeletal | Lymphocyte | — | 2 | 10 | 27 | |
| 303 | APOE levels | PROLV000124 | 5.01 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 304 | LAYN/PTPRN2 ratio | PRORT001433 | 4.98 | Protein ratios | Neural / glial | 5 | 2 | 13 | 28 | |
| 305 | PRSS53 levels | PROLV001647 | 4.94 | Protein levels | Hepatocyte | 56 | 2 | 9 | 25 | |
| 306 | FGFR4 levels | PROLV000802 | 4.88 | Protein levels | Hepatocyte | 102 | 2 | 8 | 24 | |
| 307 | Urbanicity | SOCIO000029 | 4.88 | Socioeconomic | Melanocyte | 0 | 3 | 9 | 12 | |
| 308 | SFRP4 levels | PROLV001846 | 4.87 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 309 | Iron deficiency anaemia | HEMAT000011 | 4.81 | Hematologic | Hepatocyte | 16 | 1 | 3 | 9 | |
| 310 | Gut microbial pathway abundance | GASTR000038 | 4.75 | Gastrointestinal | Hepatocyte | 0 | 3 | 9 | 26 | |
| 311 | CETN2/TDRKH ratio | PRORT000608 | 4.72 | Protein ratios | Myeloid | 0 | 2 | 5 | 12 | |
| 312 | Occupational respiratory symptoms | RESPI000030 | 4.72 | Respiratory | Neural / glial | 0 | 1 | 4 | 11 | |
| 313 | AAGAB levels | PROLV000003 | 4.71 | Protein levels | Hepatocyte | 3 | 1 | 8 | 17 | |
| 314 | Cellulitis and abscess | IMMUN000055 | 4.70 | Immunologic | Neural / glial | 5 | 4 | 11 | 20 | |
| 315 | EIF4G1/MAVS ratio | PRORT001011 | 4.70 | Protein ratios | Myeloid | 22 | 3 | 9 | 16 | |
| 316 | HNRNPK/VASH1 ratio | PRORT001294 | 4.67 | Protein ratios | Myeloid | 1 | 1 | 6 | 9 | |
| 317 | FEN1 levels | PROLV000789 | 4.66 | Protein levels | Neural / glial | 1 | 4 | 9 | 21 | |
| 318 | LSP1 levels | PROLV001238 | 4.66 | Protein levels | Neural / glial | 14 | 6 | 14 | 47 | |
| 319 | Arterial dissection | VASCU000003 | 4.65 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 320 | Restless legs syndrome, RLS | NEURO000012 | 4.64 | Neurologic | Neural / glial | 2 | 1 | 6 | 9 | |
| 321 | ACY1/DCXR ratio | PRORT000019 | 4.64 | Protein ratios | Hepatocyte | 6 | 2 | 10 | 15 | |
| 322 | SIRT1 levels | PROLV001869 | 4.64 | Protein levels | Muscle / cardiac | 6 | 2 | 11 | 20 | |
| 323 | Refractive errors | OPHTH000034 | 4.64 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 324 | Physical activity, none | BEHAV000005 | 4.63 | Behavioural | Myeloid | 0 | 4 | 15 | 23 | |
| 325 | KLK6/MOG ratio | PRORT001409 | 4.59 | Protein ratios | Myeloid | 8 | 4 | 12 | 15 | |
| 326 | GPKOW/PXN ratio | PRORT001239 | 4.58 | Protein ratios | Myeloid | 0 | 1 | 5 | 9 | |
| 327 | Sebaceous gland disorder | DERMA000034 | 4.57 | Dermatologic | Myeloid | 30 | 2 | 9 | 5 | |
| 328 | LDLR levels | PROLV001194 | 4.56 | Protein levels | Myeloid | 136 | 0 | 4 | 9 | |
| 329 | Hospital stay | MISCL000024 | 4.53 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 330 | Erectile dysfunction | VASCU000048 | 4.51 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 331 | CCL8 levels | PROLV000300 | 4.49 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 332 | Medication, analgesic | MISCL000034 | 4.49 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 333 | CALCOCO1/CRACR2A ratio | PRORT000293 | 4.46 | Protein ratios | Muscle / cardiac | 0 | 1 | 19 | 32 | |
| 334 | Corpus callosum volume | NIMAG000021 | 4.46 | Neuroimaging | Neural / glial | 35 | 1 | 3 | 10 | |
| 335 | GMPR levels | PROLV000902 | 4.44 | Protein levels | Neural / glial | 10 | 4 | 7 | 18 | |
| 336 | CRADD/FADD ratio | PRORT000745 | 4.43 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 7 | |
| 337 | PTPRN2/RTBDN ratio | PRORT001724 | 4.39 | Protein ratios | Neural / glial | 7 | 2 | 6 | 18 | |
| 338 | Lymphatic disorder | HEMAT000020 | 4.38 | Hematologic | Myeloid | 0 | 1 | 7 | 9 | |
| 339 | Drug hypersensitivity | IMMUN000006 | 4.38 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 340 | BLVRB/HAGH ratio | PRORT000241 | 4.36 | Protein ratios | Neural / glial | 22 | 2 | 7 | 8 | |
| 341 | Tubulointerstitial kidney disease | NEPHR000025 | 4.35 | Nephrourologic | Lymphocyte | 2 | 0 | 8 | 17 | |
| 342 | CNPY4/ERBIN ratio | PRORT000679 | 4.35 | Protein ratios | Hepatocyte | 19 | 4 | 7 | 19 | |
| 343 | PLAUR levels | PROLV001573 | 4.34 | Protein levels | Muscle / cardiac | 4 | 3 | 7 | 25 | |
| 344 | Sex-differentiated cardiometabolic traits | MISCL000002 | 4.33 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 345 | MNDA/NCF2 ratio | PRORT001550 | 4.33 | Protein ratios | Myeloid | 13 | 2 | 5 | 6 | |
| 346 | Consultant specialty, trauma and orthopaedics | MISCL000019 | 4.31 | Miscellaneous | Stromal / connective | 2 | 5 | 15 | 14 | |
| 347 | Birth complication | REPRO000036 | 4.30 | Reproductive | Muscle / cardiac | 0 | 0 | 7 | 16 | |
| 348 | GLB1/GUSB ratio | PRORT001215 | 4.29 | Protein ratios | Hepatocyte | 40 | 2 | 8 | 12 | |
| 349 | Oestrogen metabolite | ENDOC000009 | 4.28 | Endocrine | Hepatocyte | 6 | 2 | 8 | 12 | |
| 350 | Chronic bronchitis | RESPI000010 | 4.26 | Respiratory | Neural / glial | 1 | 1 | 2 | 7 | |
| 351 | APOF levels | PROLV000125 | 4.22 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 352 | Hypothyroidism, congenital iodine deficiency | ENDOC000013 | 4.21 | Endocrine | Muscle / cardiac | 0 | 1 | 5 | 11 | |
| 353 | Medical device use, CPAP | RESPI000024 | 4.20 | Respiratory | Hepatocyte | 0 | 3 | 6 | 19 | |
| 354 | ZBTB16 levels | PROLV002209 | 4.18 | Protein levels | Muscle / cardiac | 43 | 3 | 6 | 15 | |
| 355 | Medication, anti-malarial | IMMUN000083 | 4.16 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 356 | EIF4EBP1 levels | PROLV000697 | 4.16 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 357 | Sleep disorder | PSYCH000039 | 4.15 | Psychiatric | Neural / glial | 13 | 1 | 4 | 4 | |
| 358 | Gut microbial abundance, Staphylococcus | GASTR000036 | 4.15 | Gastrointestinal | Lymphocyte | 0 | 1 | 6 | 11 | |
| 359 | Operation, gastrointestinal | GASTR000039 | 4.12 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 360 | Family history, dyslipidaemia | METBL000010 | 4.12 | Metabolic | Hepatocyte | 64 | 1 | 6 | 10 | |
| 361 | TEX101 levels | PROLV002010 | 4.10 | Protein levels | Pancreatic epithelium | 0 | 0 | 5 | 7 | |
| 362 | Pain, none | MSKEL000041 | 4.09 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 363 | Family history, hypertension | VASCU000022 | 4.08 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 364 | NPPB levels | PROLV001424 | 4.08 | Protein levels | Muscle / cardiac | 22 | 3 | 8 | 18 | |
| 365 | HGF/PLAUR ratio | PRORT001285 | 4.06 | Protein ratios | Hepatocyte | 46 | 2 | 13 | 18 | |
| 366 | FST levels | PROLV000829 | 4.03 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 367 | Psychiatric disorder | PSYCH000016 | 4.01 | Psychiatric | Neural / glial | 0 | 2 | 7 | 11 | |
| 368 | Fatty acids metabolites | METAB000052 | 3.96 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 369 | Luteinizing hormone | ENDOC000008 | 3.95 | Endocrine | Muscle / cardiac | 0 | 5 | 7 | 15 | |
| 370 | SCRG1 levels | PROLV001793 | 3.93 | Protein levels | Stromal / connective | 1 | 0 | 6 | 7 | |
| 371 | PCOLCE levels | PROLV001510 | 3.92 | Protein levels | Neural / glial | 1 | 2 | 6 | 14 | |
| 372 | DOK2/PPP1R2 ratio | PRORT000942 | 3.91 | Protein ratios | Hepatocyte | 4 | 3 | 8 | 19 | |
| 373 | Body fat percentage, hormone-adjusted | BCOMP000001 | 3.87 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 374 | Viral wart | IMMUN000079 | 3.87 | Immunologic | Lymphocyte | 7 | 4 | 11 | 39 | |
| 375 | Ocular alignment disorder | OPHTH000023 | 3.87 | Ophthalmic | Myeloid | 9 | 4 | 9 | 17 | |
| 376 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 3.87 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 377 | HLA-DQA2 levels | PROLV000974 | 3.87 | Protein levels | Neural / glial | 5 | 4 | 7 | 9 | |
| 378 | Excessive sweating | DERMA000029 | 3.85 | Dermatologic | Myeloid | 4 | 1 | 3 | 3 | |
| 379 | CDKN1A/NCK2 ratio | PRORT000570 | 3.84 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 380 | DOK2/FADD ratio | PRORT000937 | 3.84 | Protein ratios | Hepatocyte | 12 | 2 | 5 | 12 | |
| 381 | Cerebellar volume | NIMAG000019 | 3.82 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 382 | C8B levels | PROLV000237 | 3.76 | Protein levels | Hepatocyte | 31 | 3 | 16 | 31 | |
| 383 | Pregnancy termination | BEHAV000010 | 3.76 | Behavioural | Neural / glial | 0 | 6 | 9 | 19 | |
| 384 | CD40/ITGB5 ratio | PRORT000445 | 3.74 | Protein ratios | Myeloid | 8 | 2 | 9 | 17 | |
| 385 | LEPR/NRCAM ratio | PRORT001447 | 3.71 | Protein ratios | Epithelial | 23 | 1 | 13 | 18 | |
| 386 | DPP6/SEZ6L2 ratio | PRORT000948 | 3.69 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 387 | MPHOSPH8/PSRC1 ratio | PRORT001554 | 3.66 | Protein ratios | Myeloid | 0 | 5 | 11 | 16 | |
| 388 | Phosphatidylinositols | LIPID000061 | 3.66 | Lipids | Granulosa cell | 20 | 2 | 2 | 10 | |
| 389 | SNCA levels | PROLV001908 | 3.63 | Protein levels | Myeloid | 18 | 2 | 5 | 10 | |
| 390 | Alport syndrome | NEPHR000003 | 3.62 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 391 | F11R/PARK7 ratio | PRORT001072 | 3.58 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 26 | |
| 392 | White matter volume | NIMAG000028 | 3.53 | Neuroimaging | Neural / glial | 26 | 3 | 7 | 19 | |
| 393 | CD99/KITLG ratio | PRORT000534 | 3.50 | Protein ratios | Hepatocyte | 32 | 1 | 8 | 13 | |
| 394 | Testicular dysfunction | REPRO000016 | 3.49 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 395 | Healthcare cost | SOCIO000025 | 3.47 | Socioeconomic | Neural / glial | 27 | 3 | 8 | 12 | |
| 396 | Lens disorder | OPHTH000013 | 3.44 | Ophthalmic | Stromal / connective | 3 | 5 | 8 | 10 | |
| 397 | BLVRB/CA2 ratio | PRORT000239 | 3.43 | Protein ratios | Vascular | 0 | 0 | 7 | 11 | |
| 398 | Brain ventricle volume | NIMAG000016 | 3.43 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 399 | SHISA5 levels | PROLV001856 | 3.37 | Protein levels | Myeloid | 6 | 1 | 3 | 7 | |
| 400 | NT5C3A/SCRN1 ratio | PRORT001603 | 3.34 | Protein ratios | Neural / glial | 12 | 5 | 6 | 20 | |
| 401 | Surgical history | MISCL000031 | 3.31 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 402 | Brain functional connectivity | NIMAG000002 | 3.31 | Neuroimaging | Neural / glial | 0 | 0 | 0 | 0 | |
| 403 | Exercise workload | CARDI000024 | 3.30 | Cardiac | Neural / glial | 0 | 5 | 11 | 28 | |
| 404 | ATG4A levels | PROLV000159 | 3.30 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 405 | Biliary atresia | HPBIL000002 | 3.29 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 406 | CD40LG/GP6 ratio | PRORT000451 | 3.29 | Protein ratios | Myeloid | 0 | 1 | 6 | 11 | |
| 407 | Tinnitus | AUDIO000014 | 3.23 | Auditory | Neural / glial | 2 | 4 | 8 | 12 | |
| 408 | Social and economic stability | SOCIO000028 | 3.23 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 409 | DCXR/KYNU ratio | PRORT000877 | 3.20 | Protein ratios | Hepatocyte | 13 | 3 | 10 | 15 | |
| 410 | AKT1S1/TDRKH ratio | PRORT000066 | 3.19 | Protein ratios | Stromal / connective | 0 | 3 | 9 | 28 | |
| 411 | XXYLT1 levels | PROLV002201 | 3.19 | Protein levels | Muscle / cardiac | 1 | 2 | 3 | 8 | |
| 412 | Weight-to-muscle ratio | BCOMP000010 | 3.19 | Body composition | Neural / glial | 1 | 5 | 8 | 19 | |
| 413 | Alcohol use disorder | PSYCH000044 | 3.18 | Psychiatric | Neural / glial | 2 | 3 | 5 | 12 | |
| 414 | Medication, antimigraine | NEURO000011 | 3.15 | Neurologic | Neural / glial | 0 | 2 | 7 | 8 | |
| 415 | Spondylosis | MSKEL000081 | 3.13 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 416 | Pulmonary fibrosis | RESPI000017 | 3.13 | Respiratory | Lymphocyte | 5 | 2 | 12 | 33 | |
| 417 | Hearing loss, sensorineural | AUDIO000008 | 3.11 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 418 | CLEC1B/MPIG6B ratio | PRORT000644 | 3.10 | Protein ratios | Myeloid | 4 | 4 | 12 | 13 | |
| 419 | RBP7 levels | PROLV001713 | 3.10 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 420 | ARNT levels | PROLV000144 | 3.08 | Protein levels | Myeloid | 24 | 3 | 9 | 11 | |
| 421 | PAPL levels | PROLV001494 | 3.04 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 422 | Medication, calcium channel blocker | VASCU000035 | 3.02 | Vascular | Vascular | 18 | 1 | 4 | 14 | |
| 423 | FADD/NCK2 ratio | PRORT001106 | 3.02 | Protein ratios | Neural / glial | 6 | 3 | 8 | 14 | |
| 424 | UNC5D levels | PROLV002141 | 3.01 | Protein levels | Neural / glial | 0 | 1 | 7 | 30 | |
| 425 | ECG morphology, adjusted | ECGRM000001 | 3.00 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 426 | Glutathione metabolites | METAB000006 | 3.00 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 427 | CUZD1 levels | PROLV000571 | 2.99 | Protein levels | Neural / glial | 1 | 3 | 9 | 19 | |
| 428 | Urinary incontinence | NEPHR000014 | 2.99 | Nephrourologic | Epithelial | 1 | 1 | 9 | 9 | |
| 429 | Liver volume | HPBIL000025 | 2.98 | Hepatopancreatobiliary | Myeloid | 26 | 4 | 13 | 12 | |
| 430 | Dentures | DENTA000006 | 2.96 | Dental | Neural / glial | 0 | 3 | 7 | 16 | |
| 431 | Medication, renin-angiotensin system agent | VASCU000040 | 2.94 | Vascular | Vascular | 24 | 0 | 4 | 8 | |
| 432 | ELOA/POLR2F ratio | PRORT001016 | 2.94 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 433 | Ankylosing spondylitis | IMMUN000022 | 2.94 | Immunologic | Lymphocyte | 83 | 4 | 8 | 19 | |
| 434 | Retrobulbar neuritis | NEURO000006 | 2.93 | Neurologic | Hepatocyte | — | 1 | 6 | 12 | |
| 435 | Parental longevity | AGING000003 | 2.92 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 436 | Cortical surface area | NIMAG000009 | 2.91 | Neuroimaging | Neural / glial | 78 | 0 | 0 | 0 | |
| 437 | Pain, chronic | MSKEL000034 | 2.88 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 438 | Grey matter volume | NIMAG000023 | 2.88 | Neuroimaging | Stromal / connective | 53 | 0 | 0 | 0 | |
| 439 | CEACAM8/VNN2 ratio | PRORT000590 | 2.88 | Protein ratios | Myeloid | 39 | 2 | 8 | 13 | |
| 440 | TARBP2/TDRKH ratio | PRORT001826 | 2.87 | Protein ratios | Granulosa cell | 0 | 3 | 8 | 16 | |
| 441 | Systemic lupus erythematosus, SLE | IMMUN000020 | 2.86 | Immunologic | B / plasma cell | 93 | 2 | 4 | 19 | |
| 442 | COL6A3/SPON2 ratio | PRORT000701 | 2.85 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 443 | Peripheral nerve disorder | NEURO000031 | 2.83 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 444 | CDKN1A/HBEGF ratio | PRORT000569 | 2.81 | Protein ratios | Myeloid | 24 | 2 | 8 | 17 | |
| 445 | CDKN1A/TBL1X ratio | PRORT000573 | 2.80 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 13 | |
| 446 | FLT1/VEGFA ratio | PRORT001164 | 2.78 | Protein ratios | Muscle / cardiac | 9 | 2 | 6 | 11 | |
| 447 | CREG1/GUSB ratio | PRORT000751 | 2.76 | Protein ratios | Hepatocyte | 40 | 2 | 12 | 14 | |
| 448 | EZR levels | PROLV000739 | 2.76 | Protein levels | Myeloid | 46 | 3 | 15 | 27 | |
| 449 | Cortical volume | NIMAG000022 | 2.74 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 450 | C4 levels | PROLV000233 | 2.73 | Protein levels | Vascular | 4 | 0 | 3 | 8 | |
| 451 | CASP8/RILP ratio | PRORT000324 | 2.73 | Protein ratios | Hepatocyte | 2 | 3 | 8 | 19 | |
| 452 | GAL levels | PROLV000847 | 2.72 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 453 | Raynaud phenomenon | VASCU000060 | 2.70 | Vascular | Neural / glial | 2 | 0 | 5 | 12 | |
| 454 | FLRT2/GFRA3 ratio | PRORT001161 | 2.65 | Protein ratios | Granulosa cell | 18 | 2 | 10 | 21 | |
| 455 | Pneumonia | IMMUN000069 | 2.64 | Immunologic | Hepatocyte | 27 | 1 | 4 | 13 | |
| 456 | F8 levels | PROLV000749 | 2.63 | Protein levels | Neural / glial | 2 | 2 | 6 | 11 | |
| 457 | SEMA3G levels | PROLV001808 | 2.63 | Protein levels | Hepatocyte | 80 | 1 | 6 | 8 | |
| 458 | Drug poisoning | MISCL000036 | 2.63 | Miscellaneous | Lymphocyte | 11 | 4 | 17 | 34 | |
| 459 | Benign neoplasm, Melanocytic | MALIG000004 | 2.62 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 460 | Maximal oxygen uptake | CARDI000026 | 2.61 | Cardiac | B / plasma cell | 1 | 4 | 12 | 22 | |
| 461 | Brain structural connectivity | NIMAG000007 | 2.61 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 462 | Brain general volume | NIMAG000015 | 2.61 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 463 | Dementia | NEURO000019 | 2.61 | Neurologic | Myeloid | 90 | 1 | 2 | 7 | |
| 464 | Thigh muscle volume | BMORP000020 | 2.60 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 465 | Serine | METAB000029 | 2.60 | Metabolites | Epithelial | 1 | 4 | 13 | 17 | |
| 466 | CD109 levels | PROLV000309 | 2.60 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 467 | White matter microstructure | NIMAG000013 | 2.60 | Neuroimaging | Neural / glial | 96 | 0 | 0 | 3 | |
| 468 | Subcortical volume | NIMAG000026 | 2.59 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 469 | BCL2L15 levels | PROLV000188 | 2.59 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 470 | DARS1/EIF4B ratio | PRORT000858 | 2.59 | Protein ratios | Hepatocyte | 0 | 3 | 8 | 30 | |
| 471 | CXCL5/SERPINE1 ratio | PRORT000832 | 2.58 | Protein ratios | Myeloid | 0 | 5 | 10 | 14 | |
| 472 | ADD1 levels | PROLV000039 | 2.58 | Protein levels | Lymphocyte | 1 | 1 | 9 | 31 | |
| 473 | Hospital discharge | MISCL000023 | 2.57 | Miscellaneous | Lymphocyte | 2 | 1 | 10 | 39 | |
| 474 | Iris and ciliary body disorder | OPHTH000005 | 2.54 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 475 | Operation, reproductive | REPRO000042 | 2.54 | Reproductive | Hepatocyte | 9 | 0 | 3 | 7 | |
| 476 | Eyelid, lacrimal and orbital disorder | OPHTH000016 | 2.54 | Ophthalmic | Myeloid | — | 3 | 9 | 18 | |
| 477 | Implantable cardioverter-defibrillator | CARDI000050 | 2.53 | Cardiac | Muscle / cardiac | 18 | 2 | 5 | 10 | |
| 478 | Medication, antiglaucoma | OPHTH000014 | 2.52 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 479 | Parkinson disease | NEURO000022 | 2.52 | Neurologic | Neural / glial | 25 | 6 | 11 | 24 | |
| 480 | Vertigo | AUDIO000021 | 2.52 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 481 | AKR1B1 levels | PROLV000072 | 2.51 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 482 | CA1 levels | PROLV000239 | 2.50 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 483 | Juvenile arthritis | IMMUN000032 | 2.50 | Immunologic | Salivary epithelium | 29 | 1 | 8 | 31 | |
| 484 | Hearing difficulty, none | AUDIO000005 | 2.48 | Auditory | Neural / glial | 33 | 2 | 8 | 10 | |
| 485 | EIF1AX levels | PROLV000692 | 2.44 | Protein levels | Myeloid | 1 | 1 | 5 | 7 | |
| 486 | PSRC1/SMAD1 ratio | PRORT001714 | 2.44 | Protein ratios | Muscle / cardiac | 1 | 3 | 13 | 28 | |
| 487 | Choroid plexus volume | NIMAG000020 | 2.44 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 488 | CALCOCO1/TBC1D5 ratio | PRORT000302 | 2.43 | Protein ratios | Neural / glial | 0 | 3 | 16 | 33 | |
| 489 | Infertility | REPRO000010 | 2.42 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 490 | Other ear disorder | AUDIO000004 | 2.42 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 491 | COL15A1 levels | PROLV000483 | 2.41 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 492 | FETUB levels | PROLV000790 | 2.40 | Protein levels | Hepatocyte | 44 | 1 | 7 | 7 | |
| 493 | GBP2 levels | PROLV000861 | 2.40 | Protein levels | Myeloid | 0 | 2 | 11 | 16 | |
| 494 | BLVRB/CA3 ratio | PRORT000240 | 2.39 | Protein ratios | Myeloid | 2 | 4 | 11 | 22 | |
| 495 | ATXN10/SLC27A4 ratio | PRORT000163 | 2.39 | Protein ratios | Granulosa cell | 0 | 2 | 7 | 13 | |
| 496 | GRAP2/PPP1R2 ratio | PRORT001243 | 2.38 | Protein ratios | Hepatocyte | 7 | 2 | 7 | 16 | |
| 497 | SERPINA11 levels | PROLV001815 | 2.38 | Protein levels | Hepatocyte | 203 | 1 | 7 | 13 | |
| 498 | FYN levels | PROLV000843 | 2.37 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 499 | Tendinitis | MSKEL000070 | 2.37 | Musculoskeletal | Neural / glial | 0 | 1 | 3 | 9 | |
| 500 | Hearing loss | AUDIO000013 | 2.37 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 501 | Arrhythmia | CARDI000018 | 2.37 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 502 | Respiratory infection | IMMUN000070 | 2.36 | Immunologic | Lymphocyte | 29 | 2 | 14 | 22 | |
| 503 | CD40LG/SERPINE1 ratio | PRORT000453 | 2.36 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 504 | Cardiomyopathy | CARDI000040 | 2.36 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 505 | APOBR levels | PROLV000121 | 2.34 | Protein levels | Myeloid | 25 | 2 | 9 | 17 | |
| 506 | Gut microbial abundance, CAG-177 | GASTR000020 | 2.31 | Gastrointestinal | Salivary epithelium | 0 | 0 | 7 | 5 | |
| 507 | Retinal pigment epithelium thickness | OPHTH000042 | 2.29 | Ophthalmic | Myeloid | 6 | 3 | 12 | 13 | |
| 508 | C1QTNF1 levels | PROLV000224 | 2.29 | Protein levels | Neural / glial | 27 | 2 | 10 | 34 | |
| 509 | DKK1/ZBTB16 ratio | PRORT000907 | 2.28 | Protein ratios | Myeloid | 4 | 3 | 11 | 13 | |
| 510 | Immune cell marker, pDC | HEMAT000028 | 2.27 | Hematologic | Myeloid | 0 | 3 | 12 | 14 | |
| 511 | Methionine metabolites | METAB000010 | 2.27 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 512 | MST1 levels | PROLV001344 | 2.27 | Protein levels | Hepatocyte | 131 | 3 | 6 | 10 | |
| 513 | Proline | METAB000028 | 2.27 | Metabolites | Cutaneous epithelium | 0 | 0 | 4 | 5 | |
| 514 | Medication, beta blocker | VASCU000034 | 2.26 | Vascular | Vascular | 48 | 3 | 8 | 16 | |
| 515 | CDH17/GALNT3 ratio | PRORT000548 | 2.26 | Protein ratios | Neural / glial | 1 | 1 | 8 | 8 | |
| 516 | RNASE6 levels | PROLV001740 | 2.26 | Protein levels | Myeloid | 66 | 2 | 5 | 13 | |
| 517 | EIF4B/MAP4K5 ratio | PRORT001007 | 2.25 | Protein ratios | Muscle / cardiac | 0 | 4 | 10 | 22 | |
| 518 | LEP levels | PROLV001199 | 2.25 | Protein levels | Neural / glial | 1 | 0 | 8 | 12 | |
| 519 | CLIP2/DNAJA2 ratio | PRORT000665 | 2.24 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 18 | |
| 520 | FXN/METAP1D ratio | PRORT001194 | 2.23 | Protein ratios | Neural / glial | 3 | 3 | 7 | 19 | |
| 521 | CA1/HMBS ratio | PRORT000269 | 2.22 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 522 | Brain age gap | NIMAG000004 | 2.22 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 523 | Rotator cuff disorder | MSKEL000066 | 2.21 | Musculoskeletal | Neural / glial | 0 | 4 | 7 | 8 | |
| 524 | Sciatica | NEURO000033 | 2.21 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 525 | DECR1/FXN ratio | PRORT000881 | 2.20 | Protein ratios | Muscle / cardiac | 6 | 5 | 9 | 22 | |
| 526 | Testosterone | ENDOC000010 | 2.20 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 527 | Blood disorder | HEMAT000040 | 2.20 | Hematologic | Myeloid | 1 | 3 | 8 | 12 | |
| 528 | APOC1 levels | PROLV000122 | 2.19 | Protein levels | Myeloid | 58 | 2 | 13 | 19 | |
| 529 | PSMG3 levels | PROLV001660 | 2.19 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 530 | Lysine | METAB000026 | 2.18 | Metabolites | Hepatocyte | 1 | 2 | 7 | 16 | |
| 531 | Arterial stiffness | VASCU000050 | 2.17 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 532 | Operation, cardiac | CARDI000046 | 2.16 | Cardiac | Muscle / cardiac | 20 | 2 | 5 | 7 | |
| 533 | PDCD6IP levels | PROLV001519 | 2.15 | Protein levels | Muscle / cardiac | 0 | 4 | 11 | 18 | |
| 534 | Substance use | PSYCH000049 | 2.15 | Psychiatric | Muscle / cardiac | 0 | 4 | 6 | 14 | |
| 535 | TNFSF11 levels | PROLV002076 | 2.14 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 536 | NCF2 levels | PROLV001380 | 2.13 | Protein levels | Muscle / cardiac | 2 | 2 | 7 | 14 | |
| 537 | CSNK1G2 levels | PROLV000543 | 2.13 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 9 | |
| 538 | IL6ST/LEPR ratio | PRORT001353 | 2.13 | Protein ratios | Hepatocyte | 42 | 3 | 10 | 13 | |
| 539 | Medication, macular degeneration | OPHTH000015 | 2.13 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 540 | BTN3A2 levels | PROLV000220 | 2.11 | Protein levels | Lymphocyte | 122 | 3 | 11 | 23 | |
| 541 | MB levels | PROLV001281 | 2.11 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 542 | POLR2F levels | PROLV001598 | 2.10 | Protein levels | Muscle / cardiac | 1 | 4 | 8 | 22 | |
| 543 | IL2RA levels | PROLV001069 | 2.10 | Protein levels | B / plasma cell | 106 | 3 | 16 | 27 | |
| 544 | IL1B levels | PROLV001059 | 2.09 | Protein levels | Myeloid | 2 | 3 | 11 | 18 | |
| 545 | GDI2 levels | PROLV000871 | 2.09 | Protein levels | Hepatocyte | 0 | 4 | 12 | 35 | |
| 546 | Retinal detachments and defects | OPHTH000039 | 2.09 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 547 | SPINT1 levels | PROLV001932 | 2.09 | Protein levels | Cutaneous epithelium | 74 | 0 | 5 | 11 | |
| 548 | Fatty liver disease, nonalcoholic overweight | HPBIL000030 | 2.09 | Hepatopancreatobiliary | Neural / glial | 1 | 0 | 3 | 9 | |
| 549 | SH3BP1 levels | PROLV001853 | 2.09 | Protein levels | Myeloid | 33 | 1 | 7 | 6 | |
| 550 | MNDA levels | PROLV001329 | 2.09 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 551 | MYCT1 levels | PROLV001357 | 2.08 | Protein levels | B / plasma cell | 0 | 2 | 6 | 23 | |
| 552 | Metabolon metabolite | METAB000076 | 2.08 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 553 | Heme malignancy, Leukaemia | MALIG000042 | 2.08 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 554 | SFRP2 levels | PROLV001845 | 2.07 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 555 | Brain functional activity | NIMAG000001 | 2.06 | Neuroimaging | Hepatocyte | 9 | 0 | 1 | 6 | |
| 556 | Coagulation disorder | HEMAT000017 | 2.05 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 557 | Pancreas volume | HPBIL000029 | 2.05 | Hepatopancreatobiliary | Pancreatic epithelium | 12 | 0 | 4 | 7 | |
| 558 | Lactose intolerance | METBL000003 | 2.04 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 559 | ARHGEF10 levels | PROLV000140 | 2.03 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 560 | Heart rate | CARDI000021 | 2.02 | Cardiac | Muscle / cardiac | 1,425 | 2 | 8 | 13 | |
| 561 | Diabetes, secondary | METBL000032 | 2.02 | Metabolic | Neural / glial | 0 | 2 | 10 | 24 | |
| 562 | IGFBP7 levels | PROLV001033 | 2.00 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 563 | Retirement wellbeing | SOCIO000027 | 1.99 | Socioeconomic | Neural / glial | 1 | 5 | 6 | 12 | |
| 564 | STK24/TDRKH ratio | PRORT001820 | 1.98 | Protein ratios | Myeloid | 0 | 4 | 15 | 39 | |
| 565 | Lysophosphatidylcholines | LIPID000054 | 1.97 | Lipids | Neural / glial | 26 | 2 | 4 | 15 | |
| 566 | EHMT2 levels | PROLV000691 | 1.96 | Protein levels | Granulosa cell | 1 | 3 | 10 | 14 | |
| 567 | PLXNA4/VASH1 ratio | PRORT001689 | 1.95 | Protein ratios | Myeloid | 4 | 6 | 15 | 24 | |
| 568 | Bundle branch block | CARDI000029 | 1.94 | Cardiac | Muscle / cardiac | 13 | 3 | 6 | 11 | |
| 569 | ALPI levels | PROLV000082 | 1.93 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 570 | Retinal thickness | OPHTH000043 | 1.93 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 571 | FABP2 levels | PROLV000752 | 1.93 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 572 | ERMAP levels | PROLV000729 | 1.92 | Protein levels | Myeloid | 44 | 4 | 10 | 22 | |
| 573 | SPARC/ZBTB16 ratio | PRORT001808 | 1.92 | Protein ratios | Myeloid | 4 | 2 | 9 | 14 | |
| 574 | Phenylalanine metabolites | METAB000012 | 1.90 | Metabolites | Salivary epithelium | 4 | 0 | 4 | 6 | |
| 575 | CHGA levels | PROLV000426 | 1.90 | Protein levels | Neural / glial | 33 | 2 | 5 | 12 | |
| 576 | EXTL1 levels | PROLV000738 | 1.90 | Protein levels | Myeloid | 13 | 4 | 13 | 17 | |
| 577 | VEGFC/ZBTB16 ratio | PRORT001859 | 1.88 | Protein ratios | Muscle / cardiac | 10 | 4 | 9 | 26 | |
| 578 | SNRPB2 levels | PROLV001910 | 1.87 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 579 | Abdominal adiposity | BCOMP000003 | 1.87 | Body composition | Neural / glial | 18 | 2 | 6 | 21 | |
| 580 | Gestational age at birth | REPRO000040 | 1.85 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 581 | PON1 levels | PROLV001600 | 1.85 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 582 | CA2/TGM2 ratio | PRORT000278 | 1.85 | Protein ratios | Epithelial | 17 | 3 | 7 | 15 | |
| 583 | MAP4K5/TBCB ratio | PRORT001491 | 1.84 | Protein ratios | Neural / glial | 5 | 4 | 8 | 23 | |
| 584 | CEACAM8/PGLYRP1 ratio | PRORT000588 | 1.84 | Protein ratios | Myeloid | 52 | 3 | 13 | 20 | |
| 585 | FKBP1B levels | PROLV000808 | 1.84 | Protein levels | Lymphocyte | 2 | 3 | 9 | 27 | |
| 586 | PPP1R2/USP8 ratio | PRORT001708 | 1.83 | Protein ratios | Hepatocyte | 13 | 3 | 9 | 21 | |
| 587 | CELSR2 levels | PROLV000398 | 1.83 | Protein levels | Muscle / cardiac | 14 | 2 | 9 | 15 | |
| 588 | GP5 levels | PROLV000916 | 1.82 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 589 | EBAG9/TBCC ratio | PRORT000962 | 1.82 | Protein ratios | Muscle / cardiac | 5 | 3 | 16 | 46 | |
| 590 | CYTL1 levels | PROLV000589 | 1.81 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 591 | CTSS levels | PROLV000568 | 1.81 | Protein levels | Myeloid | 61 | 2 | 8 | 10 | |
| 592 | ECG morphology, unadjusted | ECGRM000002 | 1.78 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 593 | FLT1/TGFB1 ratio | PRORT001163 | 1.78 | Protein ratios | Stromal / connective | 7 | 4 | 10 | 15 | |
| 594 | CLIC5 levels | PROLV000458 | 1.78 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 595 | SELPLG levels | PROLV001806 | 1.78 | Protein levels | Myeloid | 68 | 2 | 11 | 35 | |
| 596 | Hearing loss, age-related | AUDIO000006 | 1.77 | Auditory | Neural / glial | 4 | 3 | 13 | 14 | |
| 597 | FAM151A levels | PROLV000760 | 1.77 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 598 | APOH levels | PROLV000126 | 1.77 | Protein levels | Hepatocyte | 2 | 2 | 10 | 17 | |
| 599 | Intervertebral disc disorder | MSKEL000076 | 1.76 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 600 | Peripheral neuropathy | NEURO000032 | 1.75 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 601 | GNS levels | PROLV000907 | 1.75 | Protein levels | Myeloid | 0 | 1 | 7 | 13 | |
| 602 | Sphingomyelins | LIPID000072 | 1.75 | Lipids | Hepatocyte | 272 | 1 | 2 | 8 | |
| 603 | Acquired absence of organs | MISCL000027 | 1.74 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 604 | Skin sebum | DERMA000036 | 1.73 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 605 | Personal medical history | MISCL000011 | 1.73 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 606 | CLEC4D/HGF ratio | PRORT000655 | 1.73 | Protein ratios | Hepatocyte | 60 | 1 | 8 | 10 | |
| 607 | CA2/UBAC1 ratio | PRORT000279 | 1.73 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 608 | CCL16 levels | PROLV000282 | 1.73 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 609 | WAS levels | PROLV002184 | 1.72 | Protein levels | Hepatocyte | 25 | 2 | 6 | 11 | |
| 610 | ECG QRS-T angle | CARDI000033 | 1.72 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 611 | PSRC1 levels | PROLV001662 | 1.71 | Protein levels | Myeloid | 26 | 3 | 10 | 17 | |
| 612 | SLC51B levels | PROLV001883 | 1.71 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 | |
| 613 | INSR levels | PROLV001094 | 1.71 | Protein levels | Lymphocyte | 42 | 1 | 7 | 30 | |
| 614 | PINLYP levels | PROLV001562 | 1.71 | Protein levels | Myeloid | 66 | 4 | 10 | 14 | |
| 615 | IgA nephropathy | NEPHR000007 | 1.71 | Nephrourologic | Hepatocyte | — | 0 | 3 | 8 | |
| 616 | CDK8_CCNC levels | PROLV000381 | 1.70 | Protein levels | Hepatocyte | 0 | 2 | 8 | 12 | |
| 617 | Lysine metabolites | METAB000009 | 1.70 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 618 | IL17A levels | PROLV001051 | 1.69 | Protein levels | Myeloid | 1 | 4 | 9 | 10 | |
| 619 | FCN1 levels | PROLV000781 | 1.68 | Protein levels | Myeloid | 95 | 2 | 8 | 18 | |
| 620 | PSAPL1 levels | PROLV001654 | 1.68 | Protein levels | Cutaneous epithelium | 66 | 0 | 14 | 13 | |
| 621 | External ear disorder | AUDIO000001 | 1.68 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 622 | SMNDC1 levels | PROLV001898 | 1.67 | Protein levels | Neural / glial | 5 | 4 | 12 | 34 | |
| 623 | BACH1/SNX9 ratio | PRORT000199 | 1.67 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 11 | |
| 624 | Delivery | REPRO000004 | 1.67 | Reproductive | Myeloid | 0 | 2 | 5 | 10 | |
| 625 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 1.67 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 626 | Leg impedance | BCOMP000016 | 1.66 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 627 | TNFRSF19 levels | PROLV002067 | 1.66 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 628 | Brainstem volume | NIMAG000017 | 1.66 | Neuroimaging | Neural / glial | 10 | 3 | 5 | 15 | |
| 629 | CFHR2 levels | PROLV000415 | 1.65 | Protein levels | Myeloid | 27 | 4 | 9 | 12 | |
| 630 | ITGA6/THPO ratio | PRORT001374 | 1.65 | Protein ratios | Hepatocyte | 54 | 2 | 12 | 27 | |
| 631 | EFEMP1 levels | PROLV000679 | 1.64 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 632 | CEP43/PLXNB3 ratio | PRORT000600 | 1.64 | Protein ratios | Myeloid | 0 | 3 | 9 | 30 | |
| 633 | AK1 levels | PROLV000070 | 1.64 | Protein levels | B / plasma cell | 0 | 3 | 15 | 48 | |
| 634 | White matter lesion volume | NIMAG000027 | 1.62 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 635 | ESR1 levels | PROLV000735 | 1.61 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 636 | GDNF levels | PROLV000872 | 1.61 | Protein levels | Muscle / cardiac | 3 | 3 | 3 | 13 | |
| 637 | Enthesopathy | MSKEL000061 | 1.60 | Musculoskeletal | Lymphocyte | 0 | 0 | 1 | 11 | |
| 638 | Open wound | DERMA000043 | 1.60 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 639 | PBXIP1 levels | PROLV001501 | 1.60 | Protein levels | Myeloid | 23 | 2 | 6 | 12 | |
| 640 | Skin and subcutaneous tissue disorder | DERMA000004 | 1.59 | Dermatologic | Muscle / cardiac | 0 | 0 | 0 | 0 | |
| 641 | Cerebrovascular disease | VASCU000013 | 1.59 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 642 | Episcleritis | OPHTH000004 | 1.58 | Ophthalmic | Muscle / cardiac | 0 | 2 | 7 | 14 | |
| 643 | Insulin levels | METBL000040 | 1.58 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 644 | MTSS1 levels | PROLV001349 | 1.58 | Protein levels | Vascular | 14 | 4 | 6 | 7 | |
| 645 | FADD/PPP1R2 ratio | PRORT001109 | 1.57 | Protein ratios | Myeloid | 14 | 1 | 7 | 13 | |
| 646 | PAEP levels | PROLV001485 | 1.57 | Protein levels | Myeloid | 0 | 2 | 3 | 13 | |
| 647 | Cataract | OPHTH000012 | 1.55 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 648 | F12 levels | PROLV000743 | 1.54 | Protein levels | Myeloid | 72 | 2 | 6 | 11 | |
| 649 | Medication, anticoagulant | VASCU000030 | 1.53 | Vascular | Muscle / cardiac | 85 | 2 | 7 | 18 | |
| 650 | PGLYRP2 levels | PROLV001547 | 1.53 | Protein levels | Hepatocyte | 58 | 1 | 4 | 8 | |
| 651 | FN1 levels | PROLV000819 | 1.52 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 652 | Retinal vascular disorder | OPHTH000044 | 1.52 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 653 | HJV levels | PROLV000971 | 1.52 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 654 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 1.52 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 655 | Subarachnoid haemorrhage | VASCU000018 | 1.51 | Vascular | Granulosa cell | 0 | 0 | 5 | 6 | |
| 656 | COL9A1 levels | PROLV000493 | 1.51 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 657 | SERPINA3 levels | PROLV001817 | 1.50 | Protein levels | Myeloid | 2 | 3 | 8 | 14 | |
| 658 | Total lipids, IDL | LIPID000075 | 1.50 | Lipids | Hepatocyte | 281 | 1 | 7 | 12 | |
| 659 | MYLPF levels | PROLV001361 | 1.49 | Protein levels | Muscle / cardiac | 1 | 2 | 9 | 17 | |
| 660 | Shoulder lesion | MSKEL000068 | 1.49 | Musculoskeletal | B / plasma cell | 22 | 1 | 5 | 15 | |
| 661 | DPP6/SEZ6L ratio | PRORT000947 | 1.49 | Protein ratios | Adipose | 8 | 3 | 10 | 14 | |
| 662 | Gut microbial abundance, Holdemania | GASTR000026 | 1.48 | Gastrointestinal | Hepatocyte | 0 | 3 | 13 | 24 | |
| 663 | METAP1D/PLXNA4 ratio | PRORT001521 | 1.47 | Protein ratios | Myeloid | 5 | 4 | 11 | 24 | |
| 664 | Family history, chronic lung disease | RESPI000002 | 1.47 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 665 | GDF15 levels | PROLV000869 | 1.47 | Protein levels | Hepatocyte | 7 | 1 | 8 | 27 | |
| 666 | Mononeuropathy | NEURO000027 | 1.46 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 667 | PPP1R14A levels | PROLV001614 | 1.46 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 668 | OXT levels | PROLV001480 | 1.46 | Protein levels | Hepatocyte | 94 | 2 | 7 | 11 | |
| 669 | Gout | METBL000043 | 1.46 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 670 | FKBP5/MAP4K5 ratio | PRORT001157 | 1.46 | Protein ratios | Hepatocyte | 18 | 1 | 4 | 21 | |
| 671 | Acylcarnitines | METAB000038 | 1.46 | Metabolites | Hepatocyte | 0 | 0 | 0 | 0 | |
| 672 | Cancer, Liver | MALIG000018 | 1.45 | Malignancy | Hepatocyte | 15 | 1 | 6 | 17 | |
| 673 | Glycine | METAB000022 | 1.45 | Metabolites | Hepatocyte | 498 | 1 | 7 | 11 | |
| 674 | Immune cell marker, Monocyte | HEMAT000027 | 1.45 | Hematologic | Myeloid | 15 | 2 | 9 | 12 | |
| 675 | ASAH2 levels | PROLV000150 | 1.45 | Protein levels | Myeloid | 115 | 3 | 7 | 17 | |
| 676 | Viral haemorrhagic fever | IMMUN000075 | 1.44 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 677 | AXIN1/DOK2 ratio | PRORT000168 | 1.44 | Protein ratios | Granulosa cell | 5 | 2 | 6 | 17 | |
| 678 | ABHD14B levels | PROLV000005 | 1.43 | Protein levels | Myeloid | 12 | 3 | 5 | 17 | |
| 679 | Female genital disorder | REPRO000006 | 1.42 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 680 | C1QTNF1/COL4A1 ratio | PRORT000263 | 1.42 | Protein ratios | Granulosa cell | 30 | 2 | 5 | 14 | |
| 681 | C3 levels | PROLV000232 | 1.42 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 682 | Pregnancy complication, general | REPRO000029 | 1.41 | Reproductive | Hepatocyte | 3 | 2 | 6 | 12 | |
| 683 | Gut microbial abundance, Alistipes | GASTR000018 | 1.41 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 684 | Osteopenia | MSKEL000009 | 1.41 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 685 | TP53I3 levels | PROLV002091 | 1.40 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 686 | CD99L2/RARRES2 ratio | PRORT000539 | 1.40 | Protein ratios | Hepatocyte | 52 | 2 | 9 | 18 | |
| 687 | RNASE4 levels | PROLV001739 | 1.39 | Protein levels | Hepatocyte | 43 | 2 | 7 | 16 | |
| 688 | DNER levels | PROLV000637 | 1.38 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 689 | Medication, antiplatelet | VASCU000032 | 1.38 | Vascular | Vascular | 78 | 1 | 5 | 9 | |
| 690 | LAT/LYN ratio | PRORT001422 | 1.38 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 691 | Migraine | NEURO000010 | 1.37 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 692 | CD99 levels | PROLV000363 | 1.37 | Protein levels | Granulosa cell | 27 | 1 | 7 | 9 | |
| 693 | Ischaemic heart disease | CARDI000041 | 1.37 | Cardiac | Vascular | 595 | 3 | 10 | 19 | |
| 694 | Medication, anti-asthmatic | IMMUN000082 | 1.37 | Immunologic | Lymphocyte | 36 | 1 | 8 | 22 | |
| 695 | Cholesteryl esters | LIPID000019 | 1.37 | Lipids | Neural / glial | 42 | 2 | 4 | 15 | |
| 696 | Skin ulcer | DERMA000044 | 1.36 | Dermatologic | Granulosa cell | 1 | 1 | 2 | 6 | |
| 697 | INPP1/TBCC ratio | PRORT001360 | 1.36 | Protein ratios | Hepatocyte | 8 | 1 | 7 | 10 | |
| 698 | GBP4 levels | PROLV000862 | 1.35 | Protein levels | Neural / glial | 4 | 3 | 11 | 25 | |
| 699 | COMP/TGFBI ratio | PRORT000713 | 1.35 | Protein ratios | Myeloid | 28 | 3 | 9 | 20 | |
| 700 | FAM13A levels | PROLV000759 | 1.35 | Protein levels | Neural / glial | 16 | 4 | 8 | 22 | |
| 701 | RNASEH2A levels | PROLV001741 | 1.34 | Protein levels | Neural / glial | 5 | 3 | 11 | 24 | |
| 702 | ATXN10/PRTFDC1 ratio | PRORT000162 | 1.33 | Protein ratios | Hepatocyte | 0 | 1 | 3 | 12 | |
| 703 | SPOCK1 levels | PROLV001934 | 1.32 | Protein levels | Neural / glial | 61 | 4 | 9 | 10 | |
| 704 | CNTN3/NCS1 ratio | PRORT000687 | 1.32 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 16 | |
| 705 | FGF5 levels | PROLV000797 | 1.31 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 706 | LYZL2 levels | PROLV001255 | 1.30 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 707 | Pancreas fat | HPBIL000028 | 1.29 | Hepatopancreatobiliary | Adipose | 11 | 0 | 5 | 6 | |
| 708 | F2R levels | PROLV000745 | 1.29 | Protein levels | Lymphocyte | 23 | 2 | 5 | 21 | |
| 709 | ARG1 levels | PROLV000134 | 1.29 | Protein levels | Muscle / cardiac | 18 | 3 | 13 | 28 | |
| 710 | CXCL5 levels | PROLV000584 | 1.29 | Protein levels | Platelet | 0 | 1 | 4 | 10 | |
| 711 | CDKN1A/FOXO1 ratio | PRORT000567 | 1.29 | Protein ratios | Myeloid | 15 | 4 | 11 | 22 | |
| 712 | Stimulant use disorder | PSYCH000048 | 1.29 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 713 | CA2/PSMG3 ratio | PRORT000277 | 1.28 | Protein ratios | Lymphocyte | 3 | 3 | 4 | 19 | |
| 714 | TOP1 levels | PROLV002087 | 1.28 | Protein levels | Hepatocyte | 36 | 3 | 12 | 18 | |
| 715 | Pain, neck and shoulder | MSKEL000039 | 1.28 | Musculoskeletal | Myeloid | 0 | 4 | 9 | 20 | |
| 716 | Low hand grip strength | MSKEL000032 | 1.27 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 717 | Skin and soft tissue infection | IMMUN000073 | 1.27 | Immunologic | B / plasma cell | 9 | 1 | 8 | 22 | |
| 718 | IGLL1 levels | PROLV001036 | 1.26 | Protein levels | Muscle / cardiac | 0 | 3 | 8 | 20 | |
| 719 | Duodenal ulcer | GASTR000047 | 1.26 | Gastrointestinal | Vascular | 27 | 0 | 4 | 4 | |
| 720 | Organic acid metabolites | METAB000067 | 1.25 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 721 | NPTXR levels | PROLV001428 | 1.24 | Protein levels | Myeloid | 28 | 1 | 6 | 14 | |
| 722 | NT5C3A levels | PROLV001440 | 1.24 | Protein levels | Stromal / connective | 13 | 6 | 11 | 20 | |
| 723 | Diabetes, type 2 with complication | METBL000033 | 1.24 | Metabolic | Neural / glial | 118 | 2 | 8 | 8 | |
| 724 | ANGPTL2 levels | PROLV000096 | 1.24 | Protein levels | Stromal / connective | 48 | 3 | 17 | 12 | |
| 725 | Gut microbial abundance, Lawsonibacter | GASTR000027 | 1.24 | Gastrointestinal | Neural / glial | 0 | 1 | 3 | 6 | |
| 726 | PRND levels | PROLV001636 | 1.24 | Protein levels | Vascular | 49 | 4 | 10 | 21 | |
| 727 | DARS1/MAP4K5 ratio | PRORT000859 | 1.24 | Protein ratios | Muscle / cardiac | 6 | 5 | 14 | 19 | |
| 728 | Hippocampal volume | NIMAG000024 | 1.24 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 729 | ATOX1/SPARC ratio | PRORT000152 | 1.23 | Protein ratios | Myeloid | 10 | 1 | 6 | 11 | |
| 730 | Implant | MISCL000025 | 1.23 | Miscellaneous | Stromal / connective | 0 | 0 | 0 | 0 | |
| 731 | PADI4 levels | PROLV001484 | 1.22 | Protein levels | B / plasma cell | 1 | 4 | 15 | 26 | |
| 732 | Cerebral aneurysm | VASCU000004 | 1.22 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 733 | TPI1 levels | PROLV002093 | 1.22 | Protein levels | Neural / glial | 1 | 1 | 13 | 20 | |
| 734 | Leg mass | BCOMP000017 | 1.21 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 735 | Phosphatidylcholines | LIPID000058 | 1.21 | Lipids | Hepatocyte | 408 | 1 | 3 | 17 | |
| 736 | AHNAK2 levels | PROLV000063 | 1.21 | Protein levels | Adipose | 19 | 0 | 2 | 13 | |
| 737 | CPPED1 levels | PROLV000508 | 1.20 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 12 | |
| 738 | CCER2 levels | PROLV000277 | 1.20 | Protein levels | Muscle / cardiac | 19 | 2 | 6 | 8 | |
| 739 | CASP10/PRTFDC1 ratio | PRORT000312 | 1.20 | Protein ratios | Hepatocyte | 6 | 2 | 7 | 15 | |
| 740 | SSC4D/TNFSF10 ratio | PRORT001816 | 1.20 | Protein ratios | Hepatocyte | 11 | 2 | 7 | 14 | |
| 741 | Creatinine | NEPHR000018 | 1.20 | Nephrourologic | Hepatocyte | 2,903 | 2 | 6 | 8 | |
| 742 | Uterine or vaginal bleeding | REPRO000044 | 1.20 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 743 | RHOC/TBCB ratio | PRORT001740 | 1.19 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 744 | Spinal stenosis | MSKEL000078 | 1.18 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 745 | KDR levels | PROLV001133 | 1.18 | Protein levels | Granulosa cell | 62 | 1 | 3 | 5 | |
| 746 | GPIHBP1 levels | PROLV000924 | 1.18 | Protein levels | Granulosa cell | 39 | 1 | 6 | 8 | |
| 747 | Addison disease | ENDOC000001 | 1.18 | Endocrine | Lymphocyte | 56 | 0 | 4 | 15 | |
| 748 | EIF4G1/FKBP5 ratio | PRORT001008 | 1.18 | Protein ratios | Hepatocyte | 20 | 1 | 6 | 10 | |
| 749 | GAST levels | PROLV000857 | 1.17 | Protein levels | Salivary epithelium | 17 | 0 | 6 | 9 | |
| 750 | Blood pressure, BP, arterial | VASCU000007 | 1.17 | Vascular | Vascular | 603 | 3 | 7 | 9 | |
| 751 | FGA levels | PROLV000791 | 1.17 | Protein levels | Myeloid | 11 | 3 | 10 | 16 | |
| 752 | ALCAM/NOTCH1 ratio | PRORT000075 | 1.17 | Protein ratios | Myeloid | 36 | 2 | 14 | 20 | |
| 753 | Working hours | SOCIO000009 | 1.16 | Socioeconomic | Myeloid | 0 | 2 | 7 | 7 | |
| 754 | Gallbladder polyp | HPBIL000009 | 1.16 | Hepatopancreatobiliary | Salivary epithelium | 5 | 0 | 6 | 4 | |
| 755 | C-reactive protein | HPBIL000026 | 1.15 | Hepatopancreatobiliary | Hepatocyte | 1,267 | 3 | 10 | 20 | |
| 756 | APP/CD40LG ratio | PRORT000122 | 1.15 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 13 | 32 | |
| 757 | GPD1 levels | PROLV000921 | 1.14 | Protein levels | Neural / glial | 0 | 3 | 7 | 11 | |
| 758 | Lipoprotein particles, IDL | LIPID000044 | 1.14 | Lipids | Hepatocyte | 254 | 1 | 6 | 14 | |
| 759 | Family history, coronary artery disease | VASCU000021 | 1.14 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 760 | MNX1 levels | PROLV001330 | 1.14 | Protein levels | Neural / glial | 0 | 2 | 6 | 13 | |
| 761 | COL6A3/HSPG2 ratio | PRORT000697 | 1.14 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 762 | Medication, antipyretic | MISCL000035 | 1.14 | Miscellaneous | Lymphocyte | 0 | 3 | 10 | 20 | |
| 763 | CA1/CA3 ratio | PRORT000268 | 1.14 | Protein ratios | B / plasma cell | 1 | 5 | 16 | 23 | |
| 764 | MMP8/PGLYRP1 ratio | PRORT001544 | 1.13 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 765 | Phospholipid species | LIPID000064 | 1.13 | Lipids | Hepatocyte | 23 | 2 | 4 | 16 | |
| 766 | SNAP23/TXLNA ratio | PRORT001795 | 1.13 | Protein ratios | Hepatocyte | 0 | 2 | 12 | 24 | |
| 767 | PTPRN2 levels | PROLV001679 | 1.13 | Protein levels | Pancreatic epithelium | 1 | 0 | 3 | 3 | |
| 768 | APOA2 levels | PROLV000118 | 1.12 | Protein levels | Hepatocyte | 134 | 3 | 9 | 20 | |
| 769 | Radiotherapy | MALIG000049 | 1.12 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 770 | Gallstone disease | HPBIL000010 | 1.11 | Hepatopancreatobiliary | Hepatocyte | 400 | 1 | 8 | 13 | |
| 771 | Glycerophosphocholines | LIPID000053 | 1.11 | Lipids | Neural / glial | 0 | 2 | 11 | 17 | |
| 772 | Childhood maltreatment | PSYCH000052 | 1.11 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 773 | Hypoxaemia | RESPI000029 | 1.10 | Respiratory | Vascular | 15 | 2 | 13 | 27 | |
| 774 | Nummular dermatitis | DERMA000014 | 1.10 | Dermatologic | Vascular | 0 | 0 | 2 | 5 | |
| 775 | Pancreatitis | HPBIL000027 | 1.10 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 776 | Gut microbial abundance, UBA9475 | GASTR000037 | 1.10 | Gastrointestinal | Hepatocyte | 0 | 2 | 8 | 15 | |
| 777 | PTGR1 levels | PROLV001666 | 1.09 | Protein levels | Hepatocyte | 38 | 3 | 11 | 18 | |
| 778 | Cholesterol, esterified | LIPID000010 | 1.08 | Lipids | Hepatocyte | 379 | 2 | 8 | 13 | |
| 779 | CD84 levels | PROLV000359 | 1.08 | Protein levels | Neural / glial | 16 | 3 | 10 | 8 | |
| 780 | Sexually transmitted infection | IMMUN000072 | 1.08 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 781 | ITIH3/VCAM1 ratio | PRORT001395 | 1.07 | Protein ratios | Hepatocyte | 37 | 3 | 11 | 20 | |
| 782 | CDKN1A/FXN ratio | PRORT000568 | 1.07 | Protein ratios | Hepatocyte | 19 | 2 | 10 | 18 | |
| 783 | FKBP5/TBCC ratio | PRORT001159 | 1.06 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 14 | |
| 784 | ITGB5/VSIR ratio | PRORT001394 | 1.06 | Protein ratios | Myeloid | 8 | 4 | 7 | 14 | |
| 785 | GOLM2 levels | PROLV000909 | 1.06 | Protein levels | Myeloid | 155 | 2 | 9 | 8 | |
| 786 | CRNN levels | PROLV000528 | 1.06 | Protein levels | Cutaneous epithelium | 11 | 1 | 8 | 10 | |
| 787 | RGMB levels | PROLV001729 | 1.06 | Protein levels | Neural / glial | 21 | 1 | 6 | 7 | |
| 788 | BLVRB/CA1 ratio | PRORT000238 | 1.05 | Protein ratios | Myeloid | 1 | 2 | 5 | 11 | |
| 789 | RSPO1/SFRP1 ratio | PRORT001751 | 1.05 | Protein ratios | Hepatocyte | 0 | 1 | 5 | 8 | |
| 790 | Gut microbial abundance, Prevotella | GASTR000031 | 1.05 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 11 | |
| 791 | SSC5D levels | PROLV001948 | 1.04 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 792 | DEFA1_DEFA1B/PTGDS ratio | PRORT000886 | 1.04 | Protein ratios | Myeloid | 19 | 2 | 13 | 23 | |
| 793 | DDX58 levels | PROLV000611 | 1.04 | Protein levels | Neural / glial | 23 | 3 | 13 | 20 | |
| 794 | LCN2/PGLYRP1 ratio | PRORT001441 | 1.04 | Protein ratios | Lymphocyte | 75 | 3 | 16 | 48 | |
| 795 | NRP1 levels | PROLV001434 | 1.03 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 796 | Brain neuroimaging quality metric | NIMAG000006 | 1.03 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 797 | Lifespan | AGING000006 | 1.03 | Aging | Neural / glial | 2 | 1 | 9 | 10 | |
| 798 | ENG/NCAM2 ratio | PRORT001017 | 1.03 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 6 | 15 | |
| 799 | CASP3/SERPINE1 ratio | PRORT000319 | 1.03 | Protein ratios | Muscle / cardiac | 0 | 3 | 14 | 20 | |
| 800 | STXBP1 levels | PROLV001971 | 1.03 | Protein levels | Stromal / connective | 17 | 1 | 4 | 7 | |
| 801 | CCL3 levels | PROLV000296 | 1.02 | Protein levels | Myeloid | 77 | 3 | 9 | 19 | |
| 802 | CD40/GLOD4 ratio | PRORT000443 | 1.02 | Protein ratios | Muscle / cardiac | 0 | 1 | 4 | 9 | |
| 803 | Histidine metabolites | METAB000008 | 1.02 | Metabolites | Granulosa cell | 3 | 0 | 3 | 9 | |
| 804 | SLC4A1 levels | PROLV001882 | 1.02 | Protein levels | Lymphocyte | 0 | 3 | 7 | 28 | |
| 805 | Hydrocephalus | NEURO000002 | 1.02 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 806 | ITGB1BP2/MITD1 ratio | PRORT001385 | 1.01 | Protein ratios | Myeloid | 20 | 5 | 13 | 19 | |
| 807 | LAYN/ULBP2 ratio | PRORT001435 | 1.01 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 808 | RARRES2 levels | PROLV001706 | 1.01 | Protein levels | Myeloid | 81 | 3 | 7 | 10 | |
| 809 | ADAMTS15/CLMP ratio | PRORT000024 | 1.00 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 13 | |
| 810 | Osteoarthritis, OA | MSKEL000012 | 1.00 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 811 | Cardiovascular disease | CARDI000035 | 1.00 | Cardiac | Vascular | 145 | 3 | 8 | 11 | |
| 812 | Administrative status | MISCL000021 | 1.00 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 813 | FOXO3/MAP3K5 ratio | PRORT001178 | 1.00 | Protein ratios | Gastrointestinal epithelium | 0 | 1 | 11 | 19 | |
| 814 | Heme malignancy, Plasma cell | MALIG000046 | 1.00 | Malignancy | B / plasma cell | 3 | 2 | 14 | 35 | |
| 815 | Consultant specialty, dermatology | DERMA000005 | 0.99 | Dermatologic | B / plasma cell | 5 | 0 | 2 | 9 | |
| 816 | LTBP2/MYOC ratio | PRORT001464 | 0.99 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 817 | GCG levels | PROLV000866 | 0.99 | Protein levels | Hepatocyte | 66 | 1 | 7 | 13 | |
| 818 | ARTN levels | PROLV000148 | 0.99 | Protein levels | Myeloid | 0 | 3 | 10 | 18 | |
| 819 | Cholesterol, IDL free | LIPID000004 | 0.99 | Lipids | Hepatocyte | 608 | 1 | 9 | 12 | |
| 820 | ROBO2/SFTPD ratio | PRORT001746 | 0.99 | Protein ratios | Neural / glial | 15 | 1 | 5 | 19 | |
| 821 | CTSH levels | PROLV000565 | 0.98 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 822 | CD69/PLXNA4 ratio | PRORT000494 | 0.98 | Protein ratios | Myeloid | 29 | 3 | 6 | 18 | |
| 823 | DAB2/FKBP1B ratio | PRORT000836 | 0.98 | Protein ratios | Muscle / cardiac | 0 | 4 | 12 | 37 | |
| 824 | BSG/PCDH1 ratio | PRORT000250 | 0.98 | Protein ratios | Neural / glial | 9 | 0 | 5 | 9 | |
| 825 | CHMP1A levels | PROLV000431 | 0.98 | Protein levels | Myeloid | 11 | 4 | 7 | 15 | |
| 826 | Photodermatitis | DERMA000016 | 0.97 | Dermatologic | Lymphocyte | 2 | 2 | 11 | 29 | |
| 827 | COL18A1/RARRES2 ratio | PRORT000691 | 0.97 | Protein ratios | Myeloid | 30 | 2 | 7 | 12 | |
| 828 | CA2/HMBS ratio | PRORT000275 | 0.97 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 829 | Blood pressure, BP, systolic | VASCU000011 | 0.97 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 830 | Urticaria | IMMUN000007 | 0.97 | Immunologic | Myeloid | 26 | 0 | 0 | 5 | |
| 831 | Phosphatidylserines | LIPID000062 | 0.97 | Lipids | B / plasma cell | 0 | 0 | 5 | 17 | |
| 832 | PRR4 levels | PROLV001642 | 0.96 | Protein levels | Epithelial | 44 | 0 | 8 | 9 | |
| 833 | PDGFB/VEGFC ratio | PRORT001652 | 0.96 | Protein ratios | Neural / glial | 27 | 6 | 12 | 33 | |
| 834 | Anaemia of chronic disease | HEMAT000002 | 0.96 | Hematologic | Hepatocyte | 4 | 3 | 6 | 15 | |
| 835 | Membranous nephropathy | NEPHR000008 | 0.95 | Nephrourologic | Myeloid | 15 | 7 | 16 | 25 | |
| 836 | RILPL2 levels | PROLV001735 | 0.95 | Protein levels | Muscle / cardiac | 10 | 5 | 8 | 19 | |
| 837 | DCXR/GSTA1 ratio | PRORT000876 | 0.95 | Protein ratios | Neural / glial | 31 | 6 | 11 | 16 | |
| 838 | TNFRSF11B levels | PROLV002061 | 0.95 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 839 | CD84/DAG1 ratio | PRORT000521 | 0.95 | Protein ratios | Muscle / cardiac | 12 | 3 | 10 | 18 | |
| 840 | ICAM5 levels | PROLV001008 | 0.94 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 841 | Corneal disorder | OPHTH000003 | 0.94 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 842 | Cardiac imaging | CARDI000011 | 0.94 | Cardiac | Muscle / cardiac | 20 | 2 | 6 | 19 | |
| 843 | Loud music exposure | MISCL000006 | 0.94 | Miscellaneous | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 844 | PALM2 levels | PROLV001490 | 0.93 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 845 | AK1/PEBP1 ratio | PRORT000063 | 0.93 | Protein ratios | Myeloid | 0 | 1 | 3 | 9 | |
| 846 | PLXNA4/SPRY2 ratio | PRORT001685 | 0.93 | Protein ratios | Hepatocyte | 22 | 5 | 11 | 23 | |
| 847 | L1CAM/SEZ6L ratio | PRORT001417 | 0.92 | Protein ratios | Myeloid | 3 | 1 | 8 | 17 | |
| 848 | CDKN1A/YES1 ratio | PRORT000576 | 0.92 | Protein ratios | Muscle / cardiac | 8 | 4 | 11 | 28 | |
| 849 | Ocular motility and refraction disorder | OPHTH000024 | 0.92 | Ophthalmic | Adipose | 7 | 3 | 5 | 12 | |
| 850 | Abnormal heart sounds | CARDI000051 | 0.91 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 851 | BAG6/WASF1 ratio | PRORT000202 | 0.91 | Protein ratios | Hepatocyte | 7 | 3 | 11 | 28 | |
| 852 | GLRX2 levels | PROLV000897 | 0.91 | Protein levels | Neural / glial | 0 | 2 | 6 | 17 | |
| 853 | Complement system disorder | IMMUN000048 | 0.91 | Immunologic | Hepatocyte | 4 | 1 | 5 | 8 | |
| 854 | Asthma | IMMUN000005 | 0.91 | Immunologic | Lymphocyte | 397 | 2 | 13 | 13 | |
| 855 | Atrial fibrillation and flutter | CARDI000019 | 0.90 | Cardiac | Muscle / cardiac | 758 | 2 | 4 | 8 | |
| 856 | ENO2/SULT1A1 ratio | PRORT001031 | 0.90 | Protein ratios | Muscle / cardiac | 0 | 4 | 11 | 25 | |
| 857 | Ventricular volume | CARDI000015 | 0.89 | Cardiac | Muscle / cardiac | 83 | 2 | 7 | 15 | |
| 858 | Upper respiratory inflammation | RESPI000041 | 0.89 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 859 | GYS1/TIA1 ratio | PRORT001256 | 0.89 | Protein ratios | Hepatocyte | 13 | 3 | 12 | 19 | |
| 860 | Chalazion | OPHTH000017 | 0.88 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 861 | MFAP4 levels | PROLV001305 | 0.88 | Protein levels | Myeloid | 75 | 4 | 9 | 20 | |
| 862 | LTBP3 levels | PROLV001243 | 0.88 | Protein levels | Hepatocyte | 52 | 1 | 8 | 19 | |
| 863 | Retinal disorder | OPHTH000040 | 0.88 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 864 | MPIG6B/PLXNA4 ratio | PRORT001558 | 0.88 | Protein ratios | Myeloid | 21 | 2 | 7 | 14 | |
| 865 | F9/FURIN ratio | PRORT001091 | 0.88 | Protein ratios | Myeloid | 3 | 2 | 10 | 13 | |
| 866 | CNTN5 levels | PROLV000479 | 0.87 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 867 | GP1BB levels | PROLV000914 | 0.87 | Protein levels | Lymphocyte | 14 | 3 | 6 | 18 | |
| 868 | ANGPTL1 levels | PROLV000095 | 0.87 | Protein levels | Hepatocyte | 101 | 1 | 5 | 8 | |
| 869 | COVID-19 | IMMUN000054 | 0.87 | Immunologic | Lymphocyte | 1 | 1 | 12 | 37 | |
| 870 | CD84/CDKN1A ratio | PRORT000520 | 0.87 | Protein ratios | Hepatocyte | 12 | 3 | 8 | 16 | |
| 871 | SVEP1 levels | PROLV001982 | 0.87 | Protein levels | Vascular | 7 | 2 | 7 | 4 | |
| 872 | CCL5/CXCL3 ratio | PRORT000355 | 0.86 | Protein ratios | Muscle / cardiac | 6 | 2 | 7 | 14 | |
| 873 | CPA2 levels | PROLV000502 | 0.86 | Protein levels | Pancreatic epithelium | 57 | 0 | 5 | 5 | |
| 874 | Pregnancy complication, ectopic | REPRO000028 | 0.85 | Reproductive | Vascular | 1 | 1 | 11 | 28 | |
| 875 | ATRN levels | PROLV000163 | 0.85 | Protein levels | Vascular | 52 | 6 | 17 | 29 | |
| 876 | DLL1/TGFBR2 ratio | PRORT000919 | 0.85 | Protein ratios | Vascular | 20 | 0 | 3 | 2 | |
| 877 | Angina pectoris | CARDI000039 | 0.85 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 878 | Fatty acids, omega-3 | LIPID000024 | 0.85 | Lipids | Hepatocyte | 605 | 2 | 9 | 17 | |
| 879 | CALCOCO1/PFKFB2 ratio | PRORT000301 | 0.85 | Protein ratios | Myeloid | 1 | 5 | 10 | 23 | |
| 880 | Hypertension | VASCU000027 | 0.85 | Vascular | Vascular | 668 | 3 | 5 | 11 | |
| 881 | Gynaecomastia | BREAS000003 | 0.84 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 882 | Cholesterol, IDL | LIPID000005 | 0.84 | Lipids | Hepatocyte | 692 | 1 | 8 | 15 | |
| 883 | ENPP2/TNFRSF11B ratio | PRORT001034 | 0.84 | Protein ratios | Hepatocyte | 12 | 2 | 14 | 14 | |
| 884 | Whole body impedance | BCOMP000007 | 0.84 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 885 | Short-chain fatty acids | METAB000053 | 0.83 | Metabolites | Granulosa cell | 20 | 5 | 12 | 17 | |
| 886 | NMT1 levels | PROLV001412 | 0.83 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 887 | Arthropathy | MSKEL000013 | 0.83 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 888 | Cholesterol, LDL | LIPID000007 | 0.82 | Lipids | Hepatocyte | 1,987 | 1 | 6 | 12 | |
| 889 | NTPROBNP levels | PROLV001446 | 0.82 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 890 | Varicose veins, VV | VASCU000061 | 0.82 | Vascular | Vascular | 132 | 1 | 4 | 11 | |
| 891 | SLAMF1 levels | PROLV001875 | 0.82 | Protein levels | B / plasma cell | 22 | 2 | 12 | 27 | |
| 892 | Benign neoplasm, Colorectal | MALIG000002 | 0.82 | Malignancy | Stromal / connective | 41 | 0 | 4 | 4 | |
| 893 | MITD1/RHOC ratio | PRORT001536 | 0.82 | Protein ratios | Myeloid | 13 | 3 | 8 | 8 | |
| 894 | Cholesterol, LDL free | LIPID000006 | 0.81 | Lipids | Hepatocyte | 1,130 | 1 | 8 | 11 | |
| 895 | NRAC levels | PROLV001431 | 0.81 | Protein levels | Myeloid | 0 | 2 | 5 | 13 | |
| 896 | Snoring | RESPI000036 | 0.81 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 897 | TBCB/TBCC ratio | PRORT001827 | 0.81 | Protein ratios | Myeloid | 1 | 2 | 10 | 23 | |
| 898 | Dihydrosphingomyelins | LIPID000067 | 0.81 | Lipids | Epithelial | 0 | 0 | 6 | 10 | |
| 899 | Fatty acids, undecenoic acid | LIPID000030 | 0.81 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 900 | Heart rate variability | CARDI000022 | 0.81 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 901 | Pulmonary nodule | RESPI000018 | 0.80 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 902 | SMOC2 levels | PROLV001900 | 0.80 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 903 | NT5C3A/PRDX5 ratio | PRORT001602 | 0.80 | Protein ratios | Myeloid | 0 | 2 | 8 | 14 | |
| 904 | Mammary dysplasia | BREAS000001 | 0.80 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 905 | CA11 levels | PROLV000240 | 0.80 | Protein levels | Adipose | 0 | 3 | 6 | 23 | |
| 906 | Breast disorder | BREAS000002 | 0.80 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 907 | Visual impairment | OPHTH000046 | 0.79 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 908 | Phospholipids, IDL | LIPID000049 | 0.79 | Lipids | Hepatocyte | 536 | 2 | 8 | 13 | |
| 909 | Cancer, Stomach | MALIG000030 | 0.79 | Malignancy | Myeloid | 2 | 0 | 1 | 9 | |
| 910 | DOK2/LACTB2 ratio | PRORT000939 | 0.79 | Protein ratios | Hepatocyte | 2 | 2 | 6 | 11 | |
| 911 | RBP2 levels | PROLV001711 | 0.79 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 912 | CTSD/PRCP ratio | PRORT000799 | 0.79 | Protein ratios | Hepatocyte | 16 | 2 | 10 | 21 | |
| 913 | Barrett's oesophagus | GASTR000046 | 0.79 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 914 | AGRN/BTN2A1 ratio | PRORT000046 | 0.78 | Protein ratios | Adipose | 70 | 2 | 7 | 7 | |
| 915 | DECR1/METAP1D ratio | PRORT000883 | 0.78 | Protein ratios | Muscle / cardiac | 0 | 1 | 5 | 13 | |
| 916 | ADAM15 levels | PROLV000026 | 0.78 | Protein levels | Lymphocyte | 72 | 2 | 16 | 38 | |
| 917 | F9 levels | PROLV000750 | 0.78 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 918 | Cholesteryl esters, HDL | LIPID000015 | 0.77 | Lipids | Hepatocyte | 2,085 | 3 | 9 | 17 | |
| 919 | CHCHD6 levels | PROLV000425 | 0.77 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 920 | Cholesterol, free | LIPID000011 | 0.77 | Lipids | Hepatocyte | 300 | 1 | 6 | 17 | |
| 921 | CDKN1A/TXLNA ratio | PRORT000575 | 0.77 | Protein ratios | Myeloid | 15 | 4 | 12 | 14 | |
| 922 | METAP2/USP8 ratio | PRORT001526 | 0.77 | Protein ratios | Hepatocyte | 0 | 2 | 3 | 11 | |
| 923 | PLA2G4A/SNX9 ratio | PRORT001676 | 0.77 | Protein ratios | Myeloid | 0 | 2 | 3 | 11 | |
| 924 | Cholesterol, HDL | LIPID000003 | 0.76 | Lipids | Hepatocyte | 4,625 | 3 | 8 | 17 | |
| 925 | ABHD14B/SCRN1 ratio | PRORT000006 | 0.76 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 7 | 10 | |
| 926 | Cholesterol, HDL free | LIPID000001 | 0.76 | Lipids | Hepatocyte | 1,923 | 3 | 8 | 19 | |
| 927 | AZU1 levels | PROLV000168 | 0.76 | Protein levels | Muscle / cardiac | 18 | 3 | 4 | 8 | |
| 928 | Pregnancy complication, obstructed labour | REPRO000031 | 0.76 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 929 | ANXA3/ANXA4 ratio | PRORT000103 | 0.76 | Protein ratios | Myeloid | 0 | 3 | 10 | 14 | |
| 930 | ADGRG2/SDC1 ratio | PRORT000037 | 0.75 | Protein ratios | Melanocyte | 30 | 1 | 8 | 8 | |
| 931 | Acquired foot deformities | MSKEL000052 | 0.75 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 932 | IPCEF1/SERPINE1 ratio | PRORT001361 | 0.75 | Protein ratios | Lymphocyte | 4 | 4 | 13 | 41 | |
| 933 | PLIN3/VSIR ratio | PRORT001683 | 0.75 | Protein ratios | Vascular | 4 | 2 | 3 | 14 | |
| 934 | PROK2 levels | PROLV001639 | 0.74 | Protein levels | Hepatocyte | 4 | 4 | 9 | 11 | |
| 935 | ACYP1 levels | PROLV000021 | 0.74 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 936 | IGSF3 levels | PROLV001038 | 0.74 | Protein levels | Hepatocyte | 95 | 2 | 8 | 28 | |
| 937 | BIRC2/CD40LG ratio | PRORT000235 | 0.74 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 29 | |
| 938 | CXCL5/EDAR ratio | PRORT000827 | 0.74 | Protein ratios | Myeloid | 9 | 3 | 10 | 24 | |
| 939 | PODXL2/SDC1 ratio | PRORT001696 | 0.74 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 13 | |
| 940 | PON2 levels | PROLV001601 | 0.74 | Protein levels | Hepatocyte | 91 | 2 | 9 | 17 | |
| 941 | IPCEF1/TBCC ratio | PRORT001365 | 0.73 | Protein ratios | B / plasma cell | 1 | 1 | 11 | 17 | |
| 942 | CXCL14 levels | PROLV000580 | 0.73 | Protein levels | Myeloid | 0 | 3 | 8 | 16 | |
| 943 | Sepsis | IMMUN000071 | 0.73 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 944 | Synovium, tendon and bursa disorder | MSKEL000057 | 0.73 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 945 | Hernia | GASTR000008 | 0.73 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 946 | Androgen metabolite | METAB000071 | 0.73 | Metabolites | Hepatocyte | 77 | 1 | 6 | 13 | |
| 947 | Acne | DERMA000028 | 0.73 | Dermatologic | Cutaneous epithelium | 14 | 0 | 8 | 7 | |
| 948 | Congenital cardiovascular malformations | CARDI000031 | 0.73 | Cardiac | Vascular | 0 | 4 | 10 | 28 | |
| 949 | MAP4K5/TBCC ratio | PRORT001492 | 0.73 | Protein ratios | Myeloid | 1 | 4 | 12 | 30 | |
| 950 | IL1RAP levels | PROLV001062 | 0.72 | Protein levels | Hepatocyte | 96 | 2 | 12 | 13 | |
| 951 | AXIN1/MAP2K6 ratio | PRORT000174 | 0.72 | Protein ratios | Granulosa cell | 0 | 3 | 5 | 12 | |
| 952 | ATF6 levels | PROLV000157 | 0.72 | Protein levels | Myeloid | 5 | 4 | 11 | 19 | |
| 953 | Latent factor, red cell | HEMAT000038 | 0.72 | Hematologic | Lymphocyte | 67 | 0 | 1 | 4 | |
| 954 | Brain MRI signal intensity | NIMAG000003 | 0.71 | Neuroimaging | Neural / glial | 143 | 4 | 7 | 15 | |
| 955 | Fibroblastic disorder | MSKEL000064 | 0.71 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 956 | MSTN levels | PROLV001345 | 0.71 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 957 | Cholesteryl esters, IDL | LIPID000016 | 0.71 | Lipids | Hepatocyte | 572 | 1 | 8 | 17 | |
| 958 | Family history, diabetes | METBL000009 | 0.71 | Metabolic | Hematopoietic progenitor | 0 | 1 | 1 | 5 | |
| 959 | Medication, angiotensin receptor blocker | VASCU000029 | 0.71 | Vascular | Adipose | 0 | 1 | 8 | 19 | |
| 960 | Tryptophan metabolites | METAB000015 | 0.70 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 961 | LYN/YES1 ratio | PRORT001474 | 0.70 | Protein ratios | Hepatocyte | 6 | 2 | 8 | 19 | |
| 962 | Cancer, Melanoma | MALIG000020 | 0.70 | Malignancy | Lymphocyte | 121 | 2 | 5 | 25 | |
| 963 | BLMH/SERPINE1 ratio | PRORT000237 | 0.70 | Protein ratios | Myeloid | 17 | 2 | 16 | 22 | |
| 964 | PMVK/PRDX5 ratio | PRORT001692 | 0.70 | Protein ratios | Myeloid | 1 | 4 | 11 | 25 | |
| 965 | ABHD14B/CRADD ratio | PRORT000005 | 0.69 | Protein ratios | Hepatocyte | 7 | 3 | 5 | 15 | |
| 966 | Sarcoidosis | IMMUN000080 | 0.69 | Immunologic | Lymphocyte | 82 | 3 | 15 | 37 | |
| 967 | GFRA3/LAYN ratio | PRORT001211 | 0.69 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 968 | DOK2/PPP1R12A ratio | PRORT000941 | 0.69 | Protein ratios | Hepatocyte | 9 | 4 | 11 | 17 | |
| 969 | Phospholipids, HDL | LIPID000048 | 0.69 | Lipids | Hepatocyte | 2,061 | 3 | 9 | 16 | |
| 970 | Eye disorder | OPHTH000008 | 0.69 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 971 | Ornithine metabolites | METAB000011 | 0.68 | Metabolites | B / plasma cell | 0 | 2 | 9 | 9 | |
| 972 | MAPK13 levels | PROLV001270 | 0.68 | Protein levels | Hepatocyte | 7 | 3 | 8 | 12 | |
| 973 | Glycan trait | METAB000054 | 0.68 | Metabolites | B / plasma cell | 70 | 2 | 6 | 26 | |
| 974 | Triglycerides/phosphoglycerides | LIPID000042 | 0.68 | Lipids | Hepatocyte | 839 | 3 | 8 | 17 | |
| 975 | CCN2/HBEGF ratio | PRORT000365 | 0.68 | Protein ratios | Myeloid | 66 | 3 | 14 | 13 | |
| 976 | CEBPB levels | PROLV000395 | 0.68 | Protein levels | Hepatocyte | 20 | 2 | 7 | 16 | |
| 977 | Medication, insulin therapy | METBL000027 | 0.68 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 978 | Cancer, Respiratory system | MALIG000027 | 0.68 | Malignancy | Lymphocyte | 4 | 3 | 12 | 38 | |
| 979 | IBD-Ulcerative colitis | IMMUN000031 | 0.67 | Immunologic | Myeloid | 239 | 2 | 12 | 28 | |
| 980 | Family history, skin cancer | MALIG000040 | 0.67 | Malignancy | B / plasma cell | 8 | 0 | 3 | 9 | |
| 981 | NECTIN2/TNFRSF1A ratio | PRORT001581 | 0.67 | Protein ratios | Lymphocyte | 12 | 3 | 8 | 19 | |
| 982 | TSC22D1 levels | PROLV002113 | 0.67 | Protein levels | Stromal / connective | 4 | 2 | 9 | 10 | |
| 983 | CES3 levels | PROLV000407 | 0.67 | Protein levels | Hepatocyte | 70 | 1 | 6 | 12 | |
| 984 | CXCL17/LAMP3 ratio | PRORT000823 | 0.67 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 985 | Bursitis | MSKEL000059 | 0.67 | Musculoskeletal | Hematopoietic progenitor | 0 | 1 | 3 | 7 | |
| 986 | MCAM/NCAM1 ratio | PRORT001505 | 0.67 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 987 | AXIN1/GOPC ratio | PRORT000169 | 0.66 | Protein ratios | Platelet | 12 | 4 | 11 | 21 | |
| 988 | ALDH1A1/SORD ratio | PRORT000081 | 0.66 | Protein ratios | Granulosa cell | 9 | 3 | 7 | 20 | |
| 989 | CA3 levels | PROLV000244 | 0.66 | Protein levels | Muscle / cardiac | 7 | 3 | 8 | 23 | |
| 990 | Pre-existing hypertension, pregnancy | VASCU000044 | 0.66 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 991 | CTSB levels | PROLV000560 | 0.66 | Protein levels | Myeloid | 144 | 3 | 10 | 13 | |
| 992 | IMPA1/TBCC ratio | PRORT001358 | 0.66 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 13 | |
| 993 | EFEMP1/IL18BP ratio | PRORT000987 | 0.66 | Protein ratios | Stromal / connective | 1 | 1 | 6 | 16 | |
| 994 | IGFBP3 levels | PROLV001030 | 0.65 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 995 | Gut microbial abundance, Microvirga | GASTR000029 | 0.65 | Gastrointestinal | Melanocyte | 0 | 7 | 10 | 14 | |
| 996 | Diglycerides | LIPID000038 | 0.65 | Lipids | Hepatocyte | 32 | 1 | 5 | 16 | |
| 997 | METAP1D/VASH1 ratio | PRORT001522 | 0.65 | Protein ratios | Hematopoietic progenitor | 4 | 2 | 5 | 11 | |
| 998 | KLF4 levels | PROLV001149 | 0.65 | Protein levels | Lymphocyte | 0 | 2 | 7 | 21 | |
| 999 | Wisdom tooth surgery | DENTA000005 | 0.65 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 1000 | BACH1/CD2AP ratio | PRORT000191 | 0.65 | Protein ratios | Hepatocyte | 17 | 2 | 14 | 35 |